rfhg_5710.1

Basic information about the TSS

---

TSS ID: rfhg_5710.1 TSS ID(Version3): hg_2399.1 hg_2396.1 hg_2398.1 hg_2397.1 Species: human Chr: chr1		Start: 40691595 End: 40691810 Strand: +
Source datasets	FANTOM5|PRJNA401781|PRJNA615891|PRJDB5282|PRJNA4843412 |DRA013844|PRJNA548673
Protocol	CAGE|RAMPAGE|oligo_capping|TIF-seq2|C1CAGE|NETCAGE |SLIC_CAGE|ReCappable-seq
TSS cluster detected*	11

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2155490,EH38E1340311)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000467203.5:0 ENST00000424419.6:0 ENST00000427410.6:0 ENST00000447388.7:0 ENST00000425457.6:0 ENST00000453631.5:0 ENST00000456393.6:0 AK301215:0 AK301385:0 Z70024:0 Z74792:0 BC005003:0 AB208975:0 AK300774:0 GeneID: 4802 HGNC/MGI_ID: HGNC:7806 UniProt_ID: B4DVS8 Q13952 Q14497 Q5T6K7 Nearer transcript ids and distances: D85425:2 D89986:17 ENST00000372654.5:28 U78774:31 ENST00000534399.5:198 NM_001142590.2:198 ENST00000372653.5:203 AK127677:203 ENST00000372669.8:480 view more...

Gene_name: nuclear transcription factor Y subunit gamma Gene_symbol: NFYC Gene_synonyms: CBF-C NF-YC Gene_source: HGNC:7806

TATA-Box annotation

---

Distance to TSS:	-2
Nearest PromoterID:	NM_001142589
Entrez ID:	4802
Nearest Unigene:	Hs.713051
Nearest Refseq:	NM_014223
Nearest Ensembl:	ENSG00000066136
Gene Name:	nuclear transcription factor Y subunit gamma
Gene Alias:	CBF-C|CBFC|H1TF2A|HAP5|HSM|NF-YC
Gene Type:	protein-coding
CpG%:	0.102326
GC%:	0.666667
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@NFYC p2@NFYC p3@NFYC p4@NFYC p5@NFYC p6@NFYC p7@NFYC p8@NFYC p9@NFYC
Sample		p1@NFYC	p2@NFYC	p3@NFYC	p4@NFYC	p5@NFYC	p6@NFYC	p7@NFYC	p8@NFYC	p9@NFYC
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	21.82	7.79	23.57	0.78	2.73	0.39	0.39	1.75	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	22.05	6.27	23.67	2.43	1.82	0.00	0.40	0.81	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	21.22	6.75	22.76	1.16	1.93	0.19	0.19	0.77	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	22.87	7.69	17.67	1.66	1.04	0.42	0.21	0.83	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	21.37	7.20	21.82	0.67	2.70	0.22	0.00	1.12	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	22.29	7.75	21.51	1.74	1.16	0.19	0.39	1.16	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	30.07	9.37	34.43	1.09	2.61	0.00	0.22	1.53	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	29.31	9.69	23.50	1.70	2.91	0.48	0.97	0.73	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	26.93	9.83	24.36	0.21	2.35	0.00	0.43	1.71	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	45.21	13.33	26.08	5.80	2.32	0.58	1.74	1.74	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	36.38	11.32	30.72	10.91	1.21	0.00	0.00	1.62	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	39.03	13.42	32.93	10.57	2.44	0.81	0.81	1.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	7.74	6.29	6.29	4.51	0.16	0.00	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	10.52	5.56	8.12	4.81	0.15	0.00	0.15	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	8.34	3.73	4.61	2.20	0.00	0.00	0.00	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	8.80	3.52	8.80	1.51	0.25	0.00	0.00	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	9.61	6.99	5.68	1.97	0.22	0.00	0.00	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	10.12	4.22	5.91	3.80	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	10.13	5.86	9.06	2.13	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	10.08	2.71	6.02	2.56	0.15	0.00	0.15	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	10.16	6.01	5.88	2.41	0.40	0.27	0.13	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	11.57	6.21	5.18	1.21	0.17	0.00	0.17	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	12.67	5.17	6.20	2.07	0.00	0.13	0.00	0.65	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	8.98	3.64	6.07	1.21	0.00	0.49	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	7.22	4.90	6.97	0.26	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	10.44	4.11	8.55	1.58	0.63	0.00	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	10.44	1.65	6.04	1.10	0.55	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	12.97	6.60	7.54	1.65	0.00	0.00	0.00	0.71	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	9.05	6.14	5.33	0.81	0.00	0.00	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	10.32	6.70	5.79	1.63	0.18	0.18	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	12.14	3.56	4.81	1.47	0.00	0.21	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	9.38	5.08	5.28	0.78	0.00	0.00	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	11.18	3.80	5.70	0.42	0.21	0.00	0.00	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	12.70	8.08	6.93	1.15	0.16	0.16	0.00	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	13.09	5.24	4.86	1.68	0.37	0.00	0.00	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	10.16	4.60	5.75	1.92	0.19	0.00	0.38	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	10.22	7.15	6.13	1.23	0.20	0.00	0.00	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	12.69	4.23	4.23	0.20	0.00	0.20	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	11.34	2.70	4.05	0.81	0.54	0.00	0.00	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	10.56	4.80	5.04	1.20	0.24	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	12.23	3.06	6.12	1.41	0.24	0.24	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	12.44	4.83	4.10	1.02	0.00	0.00	0.00	0.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	12.23	5.91	4.85	2.74	0.21	0.21	0.00	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	12.24	3.15	5.42	1.75	0.17	0.00	0.17	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	9.84	4.42	3.01	1.41	0.20	0.20	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	12.33	3.72	2.09	1.40	0.23	0.00	0.23	0.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	10.80	3.60	5.52	1.68	0.24	0.00	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	9.84	5.66	4.17	1.19	0.00	0.00	0.00	0.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	9.81	5.74	4.55	0.48	0.24	0.24	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	12.94	3.84	4.45	1.01	0.20	0.20	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	10.45	4.30	4.92	1.64	0.20	0.00	0.00	0.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	9.78	4.00	4.45	1.33	0.00	0.44	0.00	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	13.99	13.99	13.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	14.55	3.55	6.03	1.42	0.00	0.00	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	12.26	2.32	2.32	0.66	0.33	0.00	0.33	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	9.23	10.91	5.87	6.71	0.00	0.00	0.00	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	8.27	5.51	6.43	3.21	0.00	0.00	0.00	0.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	11.99	1.62	2.92	0.97	0.00	0.32	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	14.77	4.18	4.82	0.96	0.96	0.00	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	7.86	6.60	6.29	3.46	0.31	0.31	0.00	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	14.81	6.35	3.53	0.71	0.00	0.00	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	15.14	6.73	4.49	0.56	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	9.55	5.57	6.37	4.78	0.00	0.00	0.00	2.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	7.14	5.44	5.10	2.38	0.68	0.34	0.00	1.02	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	14.30	4.55	7.47	0.00	0.32	0.00	0.32	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	12.42	4.61	5.68	0.71	0.00	0.00	0.35	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	0.00	16.16	32.33	0.00	0.00	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	15.79	23.69	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	6.83	3.41	6.34	0.00	0.00	0.00	0.00	0.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	8.43	4.96	6.94	0.50	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	10.32	2.81	5.16	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	7.29	3.31	5.96	2.32	0.33	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	9.59	4.33	4.33	0.93	0.00	0.00	0.31	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	9.78	2.75	4.59	0.61	0.00	0.31	0.00	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	8.87	5.07	4.75	1.43	0.00	0.16	0.00	0.00	0.00
Adipocyte - breast, donor2	11327-117E4	9.95	4.17	4.81	3.05	0.80	0.00	0.64	1.60	0.48
Adipocyte - omental, donor1	11473-119C6	11.20	4.07	5.60	3.56	0.38	0.51	0.38	0.25	0.13
Adipocyte - omental, donor2	11474-119C7	5.98	2.99	2.99	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	4.02	3.01	4.35	4.69	0.33	0.33	0.00	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	5.10	3.83	5.74	0.64	0.00	0.00	0.00	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	4.40	2.20	1.10	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	8.58	4.06	2.71	0.45	0.00	0.45	0.45	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	9.21	5.56	4.87	2.26	0.87	0.17	0.00	0.35	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	15.06	6.85	4.50	4.30	0.78	0.00	0.00	0.20	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	9.52	5.66	2.57	1.29	0.26	0.26	0.00	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	13.66	5.58	5.02	0.84	0.28	0.28	0.56	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	18.81	5.29	4.11	0.00	0.59	0.59	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	18.74	8.45	7.40	11.10	1.37	0.00	0.16	0.32	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	15.17	5.49	3.87	4.52	0.32	0.00	0.00	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	13.86	9.06	3.73	2.67	0.00	0.00	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	11.13	6.12	2.23	3.90	0.00	0.00	0.00	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	10.40	4.99	3.74	4.99	1.66	0.00	0.00	0.83	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	16.33	4.27	4.02	4.77	0.25	0.75	0.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	10.80	5.56	4.91	6.22	0.33	0.00	0.00	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	10.35	5.78	3.65	3.96	1.22	0.30	0.30	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	14.14	7.29	7.29	1.33	1.10	0.22	0.00	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	11.47	5.02	6.81	0.00	1.08	0.00	0.00	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	7.19	3.59	3.59	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	17.09	10.79	10.43	2.52	1.26	0.00	0.54	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	11.71	10.04	6.69	0.00	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	12.94	7.40	6.37	1.44	0.62	0.00	0.21	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	16.36	16.48	6.41	1.49	0.23	0.23	0.11	0.11	0.00
Anulus Pulposus Cell, donor2	11463-119B5	7.84	7.10	4.65	0.73	1.22	0.24	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	8.54	7.64	6.29	0.45	0.45	0.00	0.45	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	9.12	6.08	6.08	0.87	1.30	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	4.28	8.56	6.42	0.00	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	8.07	4.78	5.08	0.90	0.30	0.30	0.00	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	11.38	6.32	5.06	1.26	0.00	0.00	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	11.22	1.98	5.94	0.00	0.00	0.00	0.00	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	7.15	2.60	2.60	0.00	0.00	0.65	0.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	12.62	8.25	6.31	0.97	0.00	0.00	0.00	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	7.13	4.75	4.75	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	6.78	6.40	3.01	1.51	0.38	0.00	0.75	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	13.79	2.90	3.63	1.45	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	6.27	3.76	5.02	1.25	0.00	1.25	2.51	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	11.53	5.44	5.60	1.65	0.16	0.49	0.16	0.33	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	12.28	10.92	4.09	1.36	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	9.05	4.37	2.26	1.21	0.00	0.30	0.30	0.45	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	7.50	2.68	4.29	0.54	0.54	1.61	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	8.69	4.53	4.53	0.94	0.19	0.00	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	10.69	4.28	2.94	1.34	0.00	0.00	0.27	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	4.88	2.93	10.73	0.98	0.00	0.00	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	7.96	5.14	3.98	1.16	0.33	0.50	0.00	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	8.41	6.00	6.00	1.20	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	3.54	7.08	7.08	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	9.26	4.80	3.77	0.51	0.51	0.51	0.00	0.51	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	4.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	6.80	3.40	9.22	1.46	0.49	0.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	11.00	4.17	5.31	1.52	0.00	0.00	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	12.11	2.42	4.85	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	9.69	2.28	6.27	2.28	0.00	0.00	0.57	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	7.91	3.42	3.63	1.50	0.43	0.21	0.00	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	9.55	3.36	3.36	1.03	0.26	0.00	0.26	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	7.51	5.63	8.91	0.94	0.00	0.00	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	11.58	4.18	5.79	1.29	0.00	0.00	0.00	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	7.13	5.71	5.71	2.14	0.71	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	6.43	4.09	4.09	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	8.13	3.61	4.52	0.30	0.30	0.30	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	10.69	1.19	2.38	1.19	0.00	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	4.58	7.63	6.10	1.02	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	8.66	5.35	3.82	0.00	0.25	0.00	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	8.26	3.81	2.54	0.00	0.64	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	11.65	3.02	6.47	0.43	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	7.20	4.45	2.75	1.06	0.21	0.42	0.00	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	5.22	4.06	3.19	0.29	0.29	0.58	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	9.45	6.61	3.78	0.94	0.00	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	8.98	5.59	2.88	0.17	0.34	0.17	0.00	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	0.00	2.32	0.00	0.00	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	6.34	4.23	4.23	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	7.29	3.65	3.43	1.72	0.86	0.21	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	9.63	4.81	4.21	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	5.83	2.92	2.19	3.64	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	10.11	4.60	5.75	0.46	0.00	0.00	0.00	0.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	0.00	0.00	0.00	0.00	0.00	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	6.10	4.83	3.56	0.51	0.00	0.25	0.25	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	10.12	6.19	5.57	0.83	0.41	0.00	0.41	0.21	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	7.04	6.12	5.20	0.31	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	6.69	7.17	5.74	0.96	0.48	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	7.76	3.55	3.10	0.67	0.44	0.22	0.22	0.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	3.05	7.63	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	6.09	6.65	7.20	0.55	0.00	0.00	0.00	1.11	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	8.74	3.71	4.24	0.53	0.26	0.26	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	10.18	5.45	2.54	0.73	0.36	0.36	0.00	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	21.12	25.42	13.26	3.32	0.74	1.11	0.61	0.12	0.00
Astrocyte - cerebellum, donor2	11580-120F5	15.40	15.75	9.93	1.54	1.03	0.17	0.17	0.34	0.17
Astrocyte - cerebellum, donor3	11661-122F5	15.52	10.70	4.82	1.68	0.42	0.21	0.21	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	17.43	14.29	7.67	5.23	0.70	1.05	0.70	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	16.99	10.35	9.87	5.66	1.78	0.32	0.32	0.65	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	16.56	12.53	7.46	3.58	1.04	0.45	0.60	0.89	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	40.94	18.12	16.63	7.68	1.83	0.11	0.46	1.49	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	42.60	19.92	15.16	6.39	2.76	0.13	0.00	1.25	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	39.26	21.74	16.96	8.31	1.59	0.23	0.11	1.37	0.00
Basophils, donor1	12241-129G9	13.34	17.26	2.09	0.78	0.26	0.78	0.26	0.00	0.00
Basophils, donor2	12242-129H1	12.63	23.09	7.94	1.44	0.00	0.36	0.36	0.36	0.00
Basophils, donor3	12243-129H2	16.61	20.43	2.65	1.91	0.15	0.44	0.88	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	11.86	4.53	6.47	0.86	0.43	0.00	0.00	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	5.49	2.74	4.57	0.46	0.46	0.00	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	4.39	4.39	3.14	0.63	0.63	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	9.36	5.20	4.99	0.42	1.04	0.21	0.00	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	9.44	5.53	5.53	1.38	0.23	0.23	0.00	0.46	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	6.66	4.68	4.32	1.62	0.72	0.00	0.00	0.36	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	44.73	30.09	10.51	7.32	1.24	1.03	0.93	0.62	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	36.57	33.31	9.08	18.63	1.16	1.63	0.70	0.47	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	36.77	18.87	4.48	2.24	0.00	2.56	1.60	0.64	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	41.37	10.34	0.00	0.00	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	19.72	16.34	3.38	1.13	0.00	2.25	3.38	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	22.46	19.49	1.48	0.37	0.00	1.86	1.86	0.19	0.00
CD14+ Monocytes, donor3	11381-118B4	17.12	20.42	2.20	1.32	0.66	2.85	1.76	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	34.25	29.15	6.23	0.00	0.00	1.70	1.13	0.57	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	32.60	23.12	3.41	0.76	0.38	0.38	3.79	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	33.53	29.59	3.94	0.33	0.33	0.66	2.30	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	42.21	46.26	2.60	0.00	0.58	0.87	1.16	0.72	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	29.27	37.11	1.51	0.30	0.00	0.91	1.21	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	38.61	41.46	4.26	0.00	0.24	0.71	2.37	1.42	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	38.33	32.98	1.17	0.17	0.17	1.67	1.17	0.50	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	27.88	27.33	0.55	0.28	0.28	0.83	0.55	1.10	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	31.98	36.94	1.98	0.00	0.50	1.24	1.74	0.74	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	39.16	29.37	0.98	0.00	0.39	1.37	1.57	0.59	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	29.73	30.80	0.71	0.18	0.53	0.53	0.53	0.89	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	32.64	40.26	1.31	0.00	0.00	0.22	1.09	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	30.67	31.37	1.64	0.00	0.47	0.47	0.94	1.17	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	34.85	33.27	2.11	0.00	0.53	0.53	1.58	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	33.28	22.19	0.00	0.00	1.11	1.11	0.00	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	40.16	43.14	1.49	0.30	0.89	0.89	0.59	1.49	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	30.13	40.11	1.80	0.00	0.80	1.40	0.80	0.80	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	30.61	49.76	1.25	0.21	0.42	1.87	1.46	1.67	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	39.12	40.04	1.14	0.23	0.23	0.92	1.83	1.37	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	24.88	34.61	1.58	0.00	0.68	0.68	1.13	0.45	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	32.30	31.43	0.44	0.00	1.75	0.87	0.87	1.31	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	41.42	38.73	1.88	0.00	0.00	0.81	1.61	0.81	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	36.11	39.08	1.05	0.17	0.17	0.17	0.70	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	42.08	40.40	2.52	0.00	0.42	0.42	0.42	1.26	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	47.76	31.60	1.10	0.00	0.18	0.73	0.92	1.29	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	32.41	29.94	1.76	0.00	1.41	1.41	0.70	1.41	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	35.98	35.98	2.63	0.00	0.00	0.00	0.88	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	34.87	27.55	0.87	0.00	0.52	0.17	1.57	0.52	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	27.13	29.36	0.37	0.00	0.00	1.12	1.49	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	34.27	37.51	1.51	0.00	0.22	1.72	1.51	0.65	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	32.35	33.99	0.41	2.05	0.00	0.41	2.46	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	29.90	28.97	1.16	0.46	0.23	0.70	0.93	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	37.35	36.65	1.16	0.00	0.23	0.70	1.62	0.46	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	29.43	34.44	1.31	0.44	0.22	1.74	0.44	0.87	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	37.19	40.66	1.62	0.23	0.00	0.92	1.39	0.69	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	30.98	34.01	3.68	0.65	0.43	0.43	2.17	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	50.61	39.55	2.65	0.16	0.62	1.87	2.18	0.62	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	38.25	36.68	2.62	0.35	0.00	4.02	3.14	0.70	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	44.82	42.81	2.68	0.22	0.00	2.23	3.12	1.11	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	34.45	33.94	1.53	1.28	0.26	0.77	2.30	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	36.01	31.84	2.42	0.88	0.22	1.10	0.44	1.54	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	34.32	32.63	2.74	0.63	0.63	0.42	1.05	0.21	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	22.36	30.48	8.13	18.29	0.00	4.06	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	31.86	23.05	14.24	22.37	0.68	4.07	2.71	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	47.64	23.82	22.78	12.43	0.00	1.04	2.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	44.78	19.72	20.79	14.39	0.00	3.20	0.53	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	49.85	33.77	23.05	35.92	1.07	3.22	2.68	1.61	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	37.90	25.97	16.14	14.74	0.00	1.40	1.40	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	36.08	28.24	18.82	10.20	0.00	1.57	2.35	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	38.23	29.00	15.82	15.82	0.00	2.64	0.00	2.64	0.00
CD19+ B Cells, donor1	11544-120B5	32.05	18.90	18.08	5.75	1.64	0.82	1.64	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	23.94	15.96	10.88	5.08	0.73	0.00	0.73	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	20.19	16.15	11.11	2.02	1.01	1.51	2.02	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	28.28	41.62	18.59	3.64	1.21	0.81	0.40	0.81	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	20.77	25.17	20.77	4.79	1.60	1.60	0.40	0.80	0.40
CD34+ Progenitors, donor1	11545-120B6	20.08	24.10	4.02	1.00	0.00	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	12.92	21.91	2.81	1.12	0.00	1.12	1.69	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	27.43	22.55	5.26	1.88	0.75	1.88	1.13	0.75	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	25.71	26.16	7.67	1.58	0.00	1.58	2.03	0.68	0.00
CD4+ T Cells, donor1	11225-116C1	31.78	28.56	15.71	1.43	1.79	0.36	1.79	0.71	0.00
CD4+ T Cells, donor2	11306-117C1	27.56	19.60	12.86	1.84	0.00	0.61	0.61	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	24.70	19.21	12.20	0.91	0.91	1.22	1.52	0.61	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	29.35	21.95	15.82	2.55	0.77	0.77	1.02	0.26	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	29.20	18.19	17.52	6.29	0.90	0.90	0.90	0.45	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	25.30	19.83	21.85	6.90	0.57	0.57	0.86	0.86	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	26.55	22.76	20.86	2.84	0.00	0.47	0.47	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	32.31	33.71	22.47	4.21	1.40	0.70	0.70	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	36.26	19.78	32.96	3.30	3.30	3.30	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	28.33	31.79	12.86	3.03	1.01	2.02	1.45	0.72	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	25.76	22.03	14.23	2.54	0.68	1.36	1.86	0.68	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	24.99	21.92	13.54	1.45	0.81	2.10	1.93	1.13	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	25.55	26.90	17.04	1.34	0.90	0.00	1.79	0.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	29.70	27.95	25.51	1.40	2.10	0.35	1.05	2.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	26.84	29.48	28.16	3.96	0.00	0.44	1.76	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	21.50	25.30	21.08	5.48	0.42	1.69	0.84	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	24.72	18.70	12.67	3.12	0.42	1.87	2.49	0.62	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	25.39	23.05	15.04	3.01	0.33	2.00	2.34	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	42.97	30.18	20.67	5.98	0.82	1.63	1.09	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	34.30	32.16	23.58	5.90	0.00	0.54	1.07	1.07	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	32.28	14.35	23.31	7.17	1.79	0.00	0.00	3.59	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	34.12	32.26	19.10	4.45	0.37	2.04	1.67	1.48	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	28.16	19.50	17.33	2.82	0.87	1.52	1.52	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	27.74	28.79	13.45	4.41	0.63	2.10	1.68	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	29.33	21.24	16.68	2.53	0.51	1.01	1.01	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	35.96	24.26	13.86	3.03	0.87	0.43	0.87	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	28.76	24.84	16.13	4.79	0.44	0.87	0.44	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	31.18	33.65	25.73	6.43	0.49	1.48	2.47	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	24.93	28.62	22.16	2.77	0.00	0.92	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	29.31	32.10	26.52	9.77	2.79	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	28.25	29.08	26.59	5.82	0.55	0.83	1.94	0.28	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	26.99	31.66	38.04	7.85	0.74	0.74	1.72	0.74	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	35.42	20.02	23.10	3.08	0.00	1.54	0.00	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	30.44	26.14	21.49	5.37	0.36	1.79	2.51	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	30.47	24.93	26.31	9.69	4.15	2.77	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	18.33	19.64	13.75	4.91	0.33	0.65	1.31	0.33	0.00
CD8+ T Cells, donor2	11307-117C2	18.02	12.76	9.01	2.25	0.38	0.38	0.38	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	20.70	17.67	10.86	4.29	0.00	1.26	1.51	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	13.30	7.11	5.96	0.23	0.23	0.23	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	10.06	8.87	8.39	0.24	0.72	1.20	0.24	0.48	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	12.59	9.03	7.11	0.27	0.27	0.55	0.27	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	15.01	8.71	8.11	0.30	0.30	0.00	0.30	1.20	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	13.68	9.60	8.40	0.00	0.00	0.48	0.72	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	13.19	9.32	10.23	0.00	0.23	0.45	0.68	0.68	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	13.47	9.56	8.04	0.43	0.22	0.22	0.43	0.43	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	13.69	12.63	11.05	0.53	0.53	0.26	0.53	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	15.95	7.27	11.96	0.00	0.23	0.47	0.23	0.94	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	17.81	12.38	9.36	0.30	0.00	0.91	1.51	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	13.65	14.23	5.23	2.03	0.29	0.00	0.58	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	18.12	9.06	5.86	1.07	0.53	0.53	0.00	1.07	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	11.82	7.88	6.57	0.88	0.44	0.44	0.44	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	10.93	8.65	9.56	0.91	0.91	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	14.92	7.46	4.48	2.24	0.75	0.00	1.49	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	15.13	11.52	8.28	0.00	0.72	0.72	0.72	0.72	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	9.49	6.91	7.48	0.00	0.58	0.00	0.58	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	13.43	11.78	8.25	0.00	0.47	0.00	0.24	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	12.99	9.51	10.46	0.63	0.63	0.32	1.27	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	12.30	5.54	8.00	0.31	0.62	1.23	0.31	0.92	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	13.46	8.98	8.66	0.32	0.64	0.32	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	17.21	9.18	8.80	0.38	0.38	0.76	0.00	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	20.10	9.85	7.49	0.39	0.00	0.39	1.18	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	9.08	12.10	6.05	0.76	0.00	0.76	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	32.12	15.26	15.26	6.42	0.00	1.61	1.61	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	25.18	18.88	17.49	8.39	0.70	2.10	0.00	1.40	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	30.05	15.03	18.03	1.00	1.00	0.00	0.00	3.01	0.00
Cardiac Myocyte, donor1	11525-119I4	3.66	1.83	5.48	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	16.80	6.92	4.94	0.99	0.49	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	10.31	5.05	4.74	0.63	0.74	0.42	0.11	0.21	0.00
Chondrocyte - de diff, donor1	11261-116G1	10.75	4.85	6.59	0.69	0.69	0.00	0.00	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	5.33	7.46	7.11	0.71	0.00	0.71	0.00	0.36	0.36
Chondrocyte - de diff, donor3	11410-118E6	10.13	4.10	3.98	0.80	0.23	0.68	0.23	0.68	0.00
Chondrocyte - re diff, donor2	11339-117F7	20.59	19.70	2.69	0.90	0.00	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	16.18	5.66	5.26	0.81	0.00	0.00	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	16.18	12.74	11.02	6.43	1.03	0.34	0.34	0.46	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	14.11	9.83	7.48	5.77	0.43	0.00	0.64	0.43	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	16.73	8.85	6.99	4.78	0.97	0.44	0.09	0.53	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	28.06	27.60	13.48	8.62	1.56	1.93	0.92	0.55	0.18
Corneal Epithelial Cells, donor1	11526-119I5	10.98	4.83	10.98	3.29	1.32	0.22	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	11.38	7.96	12.51	4.55	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	12.01	5.37	7.41	2.05	2.30	0.00	0.00	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	11.56	19.15	1.65	0.66	0.00	4.46	9.41	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	11.04	14.82	0.32	0.95	0.00	5.68	6.62	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	20.70	17.25	0.00	0.00	0.00	10.35	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	13.17	16.85	1.30	0.97	0.11	2.70	4.43	0.11	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	26.31	14.01	2.05	1.71	0.00	0.34	0.34	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	26.11	13.71	2.61	5.22	0.65	1.31	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	15.00	11.61	1.94	1.45	0.48	0.48	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	15.01	7.84	4.17	0.83	0.67	0.00	0.17	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	10.56	7.63	3.52	0.00	0.00	0.59	1.17	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	13.01	5.37	5.94	0.57	0.57	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	13.37	5.90	4.72	0.39	0.00	0.39	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	7.85	3.49	2.33	0.00	0.29	0.00	0.29	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	14.12	7.06	5.65	0.47	0.47	0.24	0.47	0.71	0.00
Endothelial Cells - Artery, donor3	11413-118E9	16.65	10.34	2.45	0.35	0.53	0.35	0.18	0.70	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	7.76	5.32	3.55	1.99	0.00	0.00	0.22	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	7.91	3.35	5.78	2.13	0.30	0.61	0.61	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	9.30	2.26	5.07	3.95	0.85	0.85	0.85	0.00	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	9.81	5.65	3.57	1.78	0.59	0.00	0.00	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	4.17	4.17	5.21	1.04	0.00	0.52	0.00	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	12.62	4.96	3.40	0.99	0.14	0.99	0.28	0.28	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	14.80	10.00	6.00	1.20	0.80	0.40	0.40	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	8.39	2.62	4.72	1.05	1.57	0.00	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	27.09	13.42	8.32	3.35	0.62	1.24	0.37	0.62	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	19.12	7.17	5.00	1.30	0.22	0.43	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	15.63	8.06	6.84	1.10	0.49	0.61	0.24	0.12	0.00
Endothelial Cells - Vein, donor1	11267-116G7	7.96	7.96	5.69	0.00	1.14	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	9.78	3.49	8.38	0.70	0.00	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	11.78	5.50	5.65	0.16	0.47	0.47	0.00	0.00	0.00
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	74.26	113.87	4.95	0.00	0.00	0.00	4.95	1.65	0.00
Eosinophils, donor3	12246-129H5	49.94	53.50	21.40	0.00	0.00	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	9.28	4.89	7.09	1.95	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	12.48	4.16	6.24	2.08	2.08	0.00	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	15.19	3.28	2.46	1.23	0.41	0.82	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.61	1.31	1.97	0.11	0.00	0.11	0.11	0.22	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	10.29	7.58	4.23	0.65	0.22	0.22	0.00	0.76	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	11.04	5.22	5.94	1.58	0.36	0.49	0.12	0.00	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	10.51	2.05	6.14	5.05	0.41	1.50	0.14	0.41	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	10.65	4.75	3.38	0.42	0.32	0.42	0.11	0.42	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	10.28	4.74	8.70	5.53	0.79	0.79	0.26	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	17.27	8.97	4.98	0.66	0.33	0.33	0.33	1.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	8.17	4.08	4.99	1.36	0.45	0.45	0.00	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	12.13	2.27	3.79	0.00	0.00	0.76	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	7.41	4.10	3.94	1.26	0.47	0.00	0.16	0.32	0.00
Fibroblast - Cardiac, donor4	11452-119A3	8.79	10.61	6.97	2.42	0.91	0.61	0.00	0.61	0.00
Fibroblast - Cardiac, donor5	11456-119A7	9.26	4.82	3.81	0.63	1.14	0.25	0.51	0.38	0.00
Fibroblast - Cardiac, donor6	11460-119B2	8.64	5.91	4.85	0.91	0.61	0.61	0.15	0.00	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	11.39	13.53	10.85	2.81	0.67	1.07	0.00	0.27	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	9.06	3.88	7.33	0.43	0.00	0.00	0.43	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	16.11	8.79	11.72	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	39.44	20.76	19.14	1.61	2.08	1.15	0.23	0.69	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	15.77	16.45	7.80	1.36	0.34	0.85	0.17	0.34	0.00
Fibroblast - Dermal, donor1	11269-116G9	5.17	3.52	4.70	0.23	0.47	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	9.91	7.08	10.85	0.47	0.94	0.47	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	8.22	7.01	2.30	0.48	0.60	0.00	0.12	0.24	0.00
Fibroblast - Dermal, donor4	11450-119A1	11.64	6.44	6.90	1.58	0.34	0.00	0.23	0.68	0.00
Fibroblast - Dermal, donor5	11454-119A5	12.21	9.25	8.20	0.70	1.05	0.17	0.17	0.52	0.00
Fibroblast - Dermal, donor6	11458-119A9	14.62	9.91	7.47	0.65	0.81	0.32	0.16	0.32	0.00
Fibroblast - Gingival, donor1	11237-116D4	16.87	11.24	7.08	1.04	0.42	0.21	0.21	0.42	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	16.51	7.60	6.03	3.67	0.52	0.79	0.52	0.26	0.00
Fibroblast - Gingival, donor2	11318-117D4	19.50	6.46	7.78	1.58	0.66	0.26	0.00	0.40	0.00
Fibroblast - Gingival, donor3	11394-118C8	14.50	9.86	5.80	0.97	0.48	0.29	0.19	0.10	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	13.51	10.39	3.12	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	12.33	5.64	3.35	0.53	0.00	0.00	0.00	0.35	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	20.42	9.04	6.24	0.16	0.16	0.47	0.00	1.40	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	14.74	9.33	6.49	0.68	0.27	0.27	0.14	0.54	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	15.17	7.06	6.35	0.35	0.00	1.06	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	15.50	7.02	5.85	0.88	0.29	0.29	0.00	0.58	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	18.13	7.23	7.64	0.95	0.27	0.27	0.14	0.68	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	21.28	10.42	7.24	0.44	0.33	0.22	0.00	0.22	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	14.09	9.39	5.43	1.32	0.00	0.29	0.29	0.15	0.00
Fibroblast - Lung, donor1	11270-116H1	6.80	6.80	6.80	0.00	0.00	0.00	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	8.95	5.97	8.95	1.49	1.49	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	13.93	6.54	6.33	1.69	1.06	0.21	0.00	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	13.33	12.50	10.83	0.83	0.00	0.00	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	11.19	4.20	6.99	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	9.24	3.64	4.20	0.00	1.12	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	25.98	14.61	13.80	0.81	0.00	0.00	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	15.98	11.98	3.99	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	11.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	17.26	10.28	5.04	1.55	0.78	0.19	0.58	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	22.15	10.16	9.71	1.97	0.61	0.30	0.61	1.52	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	14.69	4.59	6.73	1.53	0.92	0.00	0.61	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	12.98	3.82	2.29	0.38	0.38	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	12.42	5.67	3.51	0.00	0.27	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	8.47	3.36	3.02	0.46	0.35	0.12	0.00	0.35	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	11.50	7.18	5.97	0.55	0.33	0.33	0.22	0.33	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	21.74	9.75	14.43	0.81	1.02	0.00	0.41	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	19.38	8.02	10.02	1.34	0.67	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	13.44	4.35	5.54	0.79	0.79	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	12.30	6.75	9.53	2.58	0.79	0.60	0.99	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	6.75	6.93	4.97	1.42	0.18	0.18	0.18	0.36	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	5.52	3.55	6.90	0.59	0.39	0.59	0.20	0.39	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	12.03	9.03	6.92	2.11	0.60	0.00	0.90	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	10.90	6.91	5.18	0.54	0.43	0.65	0.22	0.22	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	9.36	4.81	4.30	2.53	0.25	1.01	0.25	0.51	0.00
Fibroblast - skin normal, donor1	11553-120C5	10.67	5.41	5.25	1.80	0.33	0.00	0.00	0.33	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	16.84	8.22	6.02	3.41	1.00	0.20	0.60	0.20	0.00
Fibroblast - skin normal, donor2	11561-120D4	10.05	7.74	7.94	2.71	0.70	0.30	0.20	0.10	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	17.53	7.56	9.37	3.32	0.91	0.30	0.60	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	11.93	5.55	5.47	2.40	0.17	0.17	0.25	0.25	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	9.23	7.01	8.38	3.42	0.51	0.68	1.03	0.17	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	10.18	5.25	7.55	2.30	0.33	0.00	0.33	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	11.50	9.59	7.88	1.49	0.64	0.21	0.32	0.00	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	12.99	6.58	7.93	1.35	0.67	0.17	0.00	0.34	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	6.59	7.53	4.55	1.41	0.47	0.16	0.00	0.31	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	22.16	0.00	0.00	0.00	0.00	0.00	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	24.40	8.72	4.36	0.87	4.36	2.61	1.74	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	11.96	4.16	3.81	1.73	0.87	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	14.83	4.94	5.20	0.52	0.00	0.52	0.00	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	10.73	5.11	4.85	1.79	1.28	0.26	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	26.03	23.73	9.95	5.36	0.00	0.77	0.77	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	21.06	14.68	15.31	5.74	0.64	0.64	1.28	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	16.26	18.26	9.98	17.69	1.43	1.43	0.86	0.29	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	7.45	10.75	12.96	23.16	1.38	0.83	0.00	0.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	11.64	15.98	6.62	12.10	0.68	0.23	0.00	0.23	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	13.08	15.06	8.92	13.08	3.17	0.79	0.59	0.20	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	12.95	10.84	15.07	17.71	1.32	0.53	0.26	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	21.20	21.85	8.15	18.92	1.30	0.65	0.33	0.33	3.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	15.04	14.59	8.84	16.36	0.88	0.44	0.88	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	12.58	17.10	7.49	9.75	1.41	0.57	0.71	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	11.21	12.31	6.28	5.30	1.35	0.12	0.37	0.25	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	14.51	11.82	7.25	4.03	1.34	0.81	0.54	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	9.54	8.18	8.55	1.49	1.24	0.12	0.12	0.50	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	10.80	9.97	9.27	3.60	1.11	0.14	0.14	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	10.98	7.73	5.69	1.83	0.61	0.20	0.41	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	9.81	8.21	11.18	4.56	0.46	0.00	0.00	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	6.60	6.73	7.97	3.74	0.75	0.12	0.00	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	8.74	6.78	9.18	2.19	1.31	0.44	0.00	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	12.11	14.77	7.09	4.14	1.48	0.00	0.30	0.59	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	10.33	10.49	10.01	3.50	1.75	0.32	0.64	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	8.94	8.49	9.38	2.68	0.45	0.00	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	13.11	11.09	10.89	3.23	0.40	1.01	0.40	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	14.76	12.38	12.21	6.11	1.87	0.34	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	17.91	14.28	12.06	5.68	0.80	0.35	0.27	0.62	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	19.56	20.08	14.36	8.84	1.87	0.42	0.10	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	16.39	17.93	13.32	5.46	0.51	0.17	0.51	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	11.84	11.84	10.07	6.20	1.88	0.33	0.22	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	18.47	11.31	9.98	5.91	1.16	0.42	0.25	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	13.88	13.27	12.05	5.51	1.02	0.41	0.41	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	9.28	11.35	9.90	4.75	0.83	0.62	0.00	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	10.61	11.30	11.07	4.96	1.38	0.35	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	13.51	10.17	9.17	5.17	1.83	0.17	0.50	0.33	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	12.56	10.36	6.61	4.41	0.88	0.00	0.00	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	11.93	11.68	10.45	6.03	1.60	0.25	0.12	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	12.81	11.35	8.75	4.54	1.30	0.65	0.16	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	10.58	9.62	12.19	5.13	0.64	0.00	0.00	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	12.41	9.29	9.38	4.83	0.95	0.09	0.09	0.38	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	11.86	10.44	6.17	3.64	0.95	0.16	0.00	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	15.20	10.64	8.82	3.34	0.61	0.00	0.00	0.61	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	12.75	8.78	7.63	4.50	1.15	0.00	0.10	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	9.22	8.34	9.22	3.95	0.66	0.22	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	14.03	8.70	7.86	4.77	0.00	0.28	0.00	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	14.72	9.63	6.48	2.31	0.74	0.09	0.09	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	18.18	7.75	6.42	2.14	0.53	0.27	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	12.09	7.65	8.72	1.38	0.61	0.46	0.00	0.31	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	12.82	10.62	6.74	1.94	1.04	0.13	0.39	0.26	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	14.91	9.49	5.69	2.17	1.90	0.00	0.00	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	16.04	10.88	5.71	2.58	1.11	0.37	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	13.38	8.77	4.17	3.73	0.22	0.44	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	18.84	9.92	5.95	3.97	0.99	0.99	0.00	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	16.88	7.65	5.14	1.45	0.40	0.26	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	14.73	5.85	3.23	0.81	0.40	0.20	0.00	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	23.64	23.89	8.39	6.35	1.02	0.51	0.25	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	16.92	18.91	9.55	7.37	1.59	0.40	0.00	0.40	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	15.25	15.10	8.32	6.16	1.23	0.15	0.62	0.62	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	13.71	11.66	11.05	11.87	1.23	0.82	0.41	0.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	24.41	11.58	10.33	5.95	0.63	0.63	0.63	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	17.80	11.87	9.04	4.80	1.98	1.98	0.00	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	17.06	14.30	7.38	9.22	0.46	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	12.37	14.85	9.90	12.37	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	17.41	15.47	9.67	3.48	0.39	0.39	0.39	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	17.65	17.65	14.44	6.42	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	22.60	8.69	10.43	13.91	0.00	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	16.27	14.32	12.37	7.16	0.98	0.00	0.33	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	14.41	9.88	12.35	9.06	0.82	0.00	1.24	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	26.66	10.00	6.66	10.00	0.00	3.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	13.70	12.58	10.35	6.99	0.28	1.12	0.00	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	17.65	14.05	10.13	4.58	0.65	0.00	0.00	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	16.78	13.42	11.74	7.55	0.84	0.84	0.84	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	15.27	12.09	13.04	6.68	1.27	0.95	0.00	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	14.61	9.17	9.17	5.43	1.70	0.34	0.00	1.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	12.53	20.88	8.35	12.53	2.09	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	12.60	18.33	17.18	9.74	1.72	0.57	0.00	1.72	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	13.32	10.95	10.06	5.33	1.18	0.00	0.00	0.89	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	18.64	11.86	6.78	15.25	0.00	0.00	0.00	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	21.95	15.74	10.77	9.94	2.07	0.00	0.41	1.24	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	15.88	15.65	11.05	9.44	0.92	0.23	0.00	0.23	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	15.81	5.27	10.54	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	13.84	12.30	8.84	9.23	2.31	0.00	0.00	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	9.78	12.39	6.85	12.06	1.30	1.30	0.33	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	12.04	9.36	10.03	8.03	1.34	0.00	0.00	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	10.40	11.56	16.57	17.34	1.93	0.00	0.39	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	29.10	17.46	15.75	8.22	2.40	2.05	0.00	2.05	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	2.48	2.48	22.36	0.00	4.97	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	9.44	10.38	11.80	8.02	1.42	0.47	0.00	0.94	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	13.28	13.28	8.45	13.88	1.21	0.60	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	17.80	15.26	16.79	11.19	3.05	0.00	0.00	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	13.16	13.96	11.97	12.36	1.20	1.20	0.00	0.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	14.80	20.23	15.29	12.83	0.99	1.48	0.00	0.00	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	9.44	8.26	20.07	15.35	2.36	0.00	0.00	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	13.42	12.84	15.75	15.17	1.17	1.17	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	9.66	6.58	21.94	13.17	5.71	0.44	0.00	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	8.48	6.78	12.72	11.87	1.70	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	14.92	6.57	7.76	13.73	0.60	0.60	1.19	2.98	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	11.16	18.44	6.79	15.53	2.91	0.00	0.00	0.97	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	26.25	6.85	2.28	0.00	0.00	0.00	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	12.89	6.24	3.33	0.42	0.42	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	20.24	13.49	6.75	0.00	0.00	1.12	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	9.51	5.71	4.12	0.63	0.00	0.00	0.32	0.95	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	4.18	4.60	5.01	0.42	0.00	0.42	0.00	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	12.42	10.21	8.94	0.35	1.28	0.70	0.00	0.58	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	12.49	8.95	14.85	0.84	1.18	0.51	0.17	0.34	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	11.15	8.42	12.97	0.00	1.59	0.00	0.00	0.68	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	15.41	11.48	14.65	0.22	0.87	0.11	0.11	0.44	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	9.46	10.10	13.32	0.43	0.64	0.43	0.00	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	11.63	8.61	12.92	0.22	1.94	0.43	0.22	0.86	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	11.21	8.97	13.45	0.00	0.62	0.37	0.12	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	10.12	9.61	11.49	0.00	0.69	0.00	0.17	0.69	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	12.17	11.53	14.10	0.32	0.64	0.00	0.32	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	10.07	9.51	7.83	2.24	0.00	2.24	0.00	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	13.85	6.92	6.49	0.00	0.43	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	13.22	7.93	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	15.17	8.47	8.11	1.06	1.41	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	13.80	6.54	7.27	2.18	0.00	0.00	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	10.67	6.82	4.02	1.05	0.35	0.35	0.00	0.52	0.00
Hepatocyte, donor1	11523-119I2	27.84	3.63	16.95	1.21	0.00	0.00	2.42	0.00	0.00
Hepatocyte, donor2	11603-120I1	25.86	8.62	10.77	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	28.22	3.07	5.52	1.84	0.61	0.61	0.00	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	42.42	16.97	9.14	8.48	0.00	1.31	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	12.41	7.69	4.37	6.29	0.17	0.70	0.35	0.17	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	12.21	5.90	4.53	0.96	0.41	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	28.66	22.29	0.00	3.18	0.00	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	20.03	0.00	0.00	0.00	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	27.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	22.15	18.00	13.84	0.00	1.38	0.00	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	15.02	2.50	0.00	0.00	0.00	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	11.87	11.87	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	33.32	15.38	17.94	2.56	2.56	0.00	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	9.14	4.57	0.00	0.00	0.00	4.57	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	17.87	8.12	16.24	3.25	0.00	0.00	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	20.01	16.67	5.00	5.00	0.00	0.00	0.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	7.26	3.63	7.26	0.00	0.00	7.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	23.82	14.56	14.56	2.65	0.00	0.00	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	17.74	4.43	8.87	4.43	0.00	0.00	0.00	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	15.71	10.48	0.00	10.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	17.64	10.71	13.23	2.52	1.89	0.00	1.89	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	21.65	20.11	1.55	0.00	0.00	3.09	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	23.90	12.92	15.50	2.58	1.94	0.00	1.29	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	17.71	12.88	16.10	11.27	1.61	0.00	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	35.85	17.11	14.67	6.52	1.63	0.00	0.81	0.81	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	31.49	16.37	12.17	1.26	1.68	0.00	0.84	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	28.74	0.00	0.00	0.00	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	30.54	12.06	13.66	3.21	0.80	0.00	0.80	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	19.39	3.69	12.93	4.62	0.92	0.00	0.92	2.77	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	15.08	30.16	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	17.94	10.38	8.97	3.30	2.36	0.47	0.47	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	19.95	7.26	10.88	3.63	2.72	0.00	0.00	2.72	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	14.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	22.60	11.84	13.99	2.15	1.08	0.00	2.15	1.08	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	31.76	10.16	10.16	7.62	3.81	0.00	0.00	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	0.00	0.00	0.00	0.00	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	25.51	9.57	12.12	1.91	1.91	0.00	0.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	25.52	14.58	16.40	5.47	1.82	0.00	0.00	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	31.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	34.99	13.57	16.42	5.00	0.00	0.00	0.00	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	36.50	29.86	13.27	9.95	0.00	6.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	20.06	12.35	10.19	1.85	1.23	0.00	0.62	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	33.36	10.54	8.78	1.76	3.51	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	22.00	22.00	12.57	6.29	6.29	3.14	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	18.78	9.04	7.65	6.26	1.39	0.70	0.00	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	30.98	17.70	22.13	2.21	0.00	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	29.18	9.73	25.94	3.24	0.00	0.00	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	23.54	17.44	11.34	6.98	0.87	0.00	1.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	49.50	22.50	33.75	9.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	20.91	3.48	3.48	3.48	0.00	0.00	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	22.40	26.67	13.87	4.27	1.07	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	29.09	16.63	15.24	6.93	0.00	0.00	0.00	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	19.95	25.65	2.85	11.40	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	21.17	13.81	11.97	9.20	3.68	0.00	0.00	2.76	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	27.23	15.13	9.08	0.00	3.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	12.42	6.21	0.00	6.21	0.00	0.00	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	11.63	17.98	19.03	3.17	2.11	2.11	1.06	2.11	0.00
Keratinocyte - epidermal, donor1	11272-116H3	8.40	3.26	4.41	1.06	0.08	0.33	0.08	0.33	0.08
Keratinocyte - epidermal, donor2	11349-117G8	11.13	5.27	7.03	1.17	1.76	0.59	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	15.14	5.58	4.73	0.85	0.57	0.09	0.09	0.57	0.00
Keratinocyte - oral, donor1	11251-116E9	15.89	9.08	11.69	6.13	1.25	0.00	0.00	0.45	0.00
Keratocytes, donor1	11527-119I6	27.85	20.29	15.13	0.00	1.38	0.34	0.00	0.34	0.00
Keratocytes, donor2	11607-120I5	9.37	8.20	3.52	1.17	2.34	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	7.71	6.52	4.94	0.79	0.59	0.00	0.00	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	19.78	8.79	4.40	4.40	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	10.79	2.16	2.16	1.08	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	10.73	10.50	7.84	4.84	1.04	0.46	0.00	0.12	0.00
Lens Epithelial Cells, donor3	11690-122I7	8.07	3.03	5.75	1.11	0.10	0.10	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	16.25	9.25	5.45	1.54	0.59	0.59	0.12	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	8.09	5.02	4.74	0.84	0.28	0.28	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	13.22	7.24	4.72	0.47	0.16	0.79	0.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	8.60	5.38	3.23	1.61	0.00	1.08	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	12.92	3.47	3.78	0.32	0.00	0.32	0.00	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	14.55	6.68	2.48	0.65	0.11	0.11	0.32	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	14.77	5.75	2.87	1.23	0.00	0.00	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	10.87	7.58	2.78	0.00	0.25	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	17.59	5.77	1.97	0.99	0.14	0.42	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	12.26	4.35	3.96	0.40	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	13.38	5.62	4.07	0.39	0.39	0.39	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	10.37	6.30	2.96	0.56	0.00	0.19	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	10.10	4.88	4.53	0.00	0.00	0.00	0.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	13.83	9.06	3.10	0.72	0.24	0.24	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	15.80	6.18	2.88	0.55	0.27	0.69	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	12.63	4.93	3.70	0.31	0.31	0.31	1.23	0.92	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	13.72	6.55	4.68	0.31	0.31	0.31	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	20.31	5.31	3.11	0.55	0.18	0.55	0.73	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	12.18	7.57	3.62	0.00	0.00	0.33	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	16.69	7.32	2.64	0.88	0.00	0.88	0.00	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	13.44	9.71	3.49	0.75	0.00	0.00	0.50	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	9.70	7.27	3.39	0.97	0.00	0.48	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	11.31	6.19	3.77	0.00	0.54	0.27	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	14.08	4.54	2.57	0.61	0.61	0.45	0.15	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	13.48	7.26	4.67	0.00	0.52	0.00	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	10.05	5.03	3.56	0.84	0.00	0.84	0.00	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	13.53	4.06	3.01	1.05	0.15	0.15	0.00	0.45	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	11.01	4.13	3.44	0.00	0.00	0.00	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	10.35	5.27	3.95	0.56	0.19	0.00	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	12.30	6.79	2.76	0.32	0.42	0.11	0.32	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	18.41	4.36	5.33	0.48	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	15.22	5.62	2.98	0.33	0.33	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	11.89	7.06	3.72	0.50	0.12	0.12	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	17.77	4.44	1.48	0.74	0.00	0.37	0.74	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	12.60	4.94	3.71	0.25	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	15.54	6.19	3.44	0.96	0.27	0.27	0.14	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	14.15	7.40	4.82	0.32	0.32	0.32	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	10.35	6.09	3.96	0.91	0.00	0.91	0.00	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	13.30	5.60	4.20	1.40	0.14	0.56	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	10.31	6.04	3.91	0.71	0.36	0.36	0.00	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	6.79	2.91	2.91	0.00	0.00	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	13.54	6.07	2.33	0.93	0.31	0.16	0.16	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	12.89	5.01	3.94	0.00	0.36	0.36	0.00	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	9.47	4.90	2.94	0.00	0.33	0.33	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	11.30	9.42	1.88	0.24	0.00	0.47	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	15.84	7.55	5.57	1.11	0.12	0.37	0.37	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	9.48	6.40	3.59	0.26	0.00	0.00	0.26	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.95	4.18	3.58	1.19	0.30	0.30	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	18.13	13.60	15.86	0.00	0.00	4.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	23.78	12.27	13.04	0.77	0.00	0.77	1.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	6.68	8.91	8.16	0.74	1.48	0.00	0.74	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	21.58	8.89	11.42	0.00	0.42	0.42	1.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	19.69	11.25	9.85	0.00	0.70	0.00	0.70	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	14.94	6.54	13.08	1.87	0.93	0.93	0.00	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	13.40	10.82	13.91	0.00	0.00	0.52	0.52	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	11.89	3.57	14.27	0.00	3.57	0.00	1.19	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	20.58	12.44	8.60	0.23	1.58	0.68	1.13	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	18.03	8.72	10.18	0.00	0.29	0.29	0.00	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	12.15	8.10	11.70	0.00	2.25	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	24.25	16.26	13.14	0.54	0.54	0.68	0.54	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	13.35	12.32	11.81	0.00	0.51	0.51	0.00	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	16.94	7.06	7.41	0.00	0.00	0.71	0.35	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	9.33	11.33	8.00	0.00	1.33	0.67	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	27.00	6.62	11.21	0.00	1.02	0.00	0.51	2.04	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	16.28	7.47	11.47	0.00	0.80	0.27	0.27	1.33	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	15.30	12.28	9.64	0.19	0.38	0.38	0.19	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	18.41	14.73	15.34	0.00	1.23	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	25.28	16.31	10.60	0.00	2.45	1.63	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	14.16	7.29	7.29	0.21	0.83	0.42	0.21	0.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	14.85	10.09	9.81	0.28	0.84	0.84	0.84	0.28	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	17.52	8.24	11.33	0.00	1.03	0.00	1.03	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	13.35	10.74	12.19	0.29	0.87	0.29	0.29	0.87	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	13.15	9.57	11.36	0.30	0.30	0.30	0.30	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	12.17	9.41	16.04	0.00	1.11	1.11	0.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	19.09	13.43	14.14	0.35	0.00	0.35	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	16.60	7.74	12.17	1.11	0.37	0.74	0.00	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	8.06	8.06	6.91	0.00	0.00	0.00	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	16.50	8.83	15.73	0.77	0.77	0.38	0.38	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	14.72	7.93	13.59	1.13	0.00	0.57	0.00	1.70	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	21.33	8.20	7.38	0.82	2.46	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	14.91	14.01	11.75	0.45	0.45	0.00	0.45	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	17.95	11.49	12.93	0.00	0.72	0.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	14.94	9.71	7.47	0.75	0.75	0.75	0.75	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	17.09	11.52	11.89	0.00	1.11	0.00	0.00	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	9.91	8.18	12.92	0.43	0.86	0.43	0.86	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	22.26	10.28	11.99	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	11.99	9.66	11.66	0.67	1.00	0.00	0.00	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	11.46	9.05	13.88	0.00	0.60	0.00	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	12.09	7.11	11.38	0.00	0.71	0.00	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	14.44	11.34	10.66	0.34	0.69	0.34	0.00	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	8.59	7.51	9.12	0.54	0.54	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	10.77	9.43	8.08	0.67	0.00	0.67	1.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	18.15	10.37	10.00	0.00	0.00	0.74	0.37	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	10.47	12.79	22.10	0.00	0.00	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	12.69	1.06	8.46	0.00	2.12	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	17.61	10.40	8.00	0.40	0.80	0.40	0.00	0.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	18.17	8.72	9.45	0.73	1.45	0.00	1.45	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	20.70	8.43	10.73	0.77	0.00	0.00	1.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	22.69	13.32	10.85	0.00	0.99	0.00	0.99	1.48	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	13.17	11.29	16.94	0.94	0.94	0.94	0.94	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	22.12	7.54	16.59	0.50	1.51	0.00	0.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	16.67	11.72	11.72	0.45	1.35	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	18.93	18.93	13.77	0.00	0.00	0.00	0.00	5.16	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	12.91	12.91	9.35	0.00	2.23	1.34	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	19.16	14.47	15.25	0.00	0.00	0.39	0.78	1.17	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	15.17	9.24	9.90	0.00	0.00	0.00	0.00	1.98	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	18.16	11.94	10.90	0.00	0.00	1.56	0.00	1.04	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	20.57	10.50	14.88	0.00	1.31	0.44	1.31	1.31	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	19.01	13.98	10.06	0.00	1.12	0.56	0.00	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	15.02	17.22	13.25	0.00	1.32	0.00	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	17.74	8.87	9.64	0.39	2.31	0.00	0.39	1.54	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	17.72	15.19	11.14	0.00	1.01	1.01	1.01	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	18.26	9.61	17.78	0.00	0.00	0.48	0.96	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	18.68	13.12	14.31	0.00	1.19	0.00	0.40	1.99	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	22.48	10.33	14.58	0.00	0.61	0.00	0.00	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	16.60	14.53	9.68	0.00	0.69	0.00	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	18.24	8.36	9.50	0.76	1.52	0.00	1.14	1.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	18.07	10.33	12.91	0.52	1.03	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	8.47	6.65	9.07	0.00	0.00	0.60	1.21	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	19.65	10.46	11.73	1.58	1.27	0.32	0.00	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	23.99	12.79	12.26	0.00	0.53	0.00	0.53	1.07	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	12.64	12.64	12.07	0.57	0.57	0.00	1.15	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	26.23	13.37	17.48	1.54	0.51	2.06	0.51	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	22.64	6.37	10.61	0.00	1.41	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	13.05	14.19	15.32	0.57	0.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	19.14	13.73	9.57	2.08	2.50	1.25	0.00	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	21.93	18.79	9.40	0.00	0.00	0.00	0.00	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	10.86	11.69	8.35	0.00	0.42	1.25	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	15.80	11.62	7.43	0.00	0.00	0.46	0.00	1.86	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	14.72	10.70	12.71	0.00	0.67	0.00	0.67	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	14.97	16.04	10.69	0.00	1.07	0.00	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	14.14	12.93	9.70	0.40	0.81	0.40	1.21	0.81	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	12.85	11.93	13.77	0.00	2.75	0.00	0.00	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	9.78	18.67	14.23	0.00	1.78	0.00	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	11.97	15.39	8.55	0.57	0.57	0.57	1.14	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	15.34	11.50	10.74	0.00	0.00	0.00	0.77	1.53	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	12.04	14.23	9.85	0.00	0.00	0.00	0.00	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	13.81	8.46	11.58	0.45	1.78	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	16.64	15.86	10.92	0.00	0.52	0.52	0.00	0.52	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	12.60	21.22	13.26	0.00	0.00	0.00	0.00	1.33	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	20.79	16.63	14.55	4.16	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	20.28	24.16	3.42	0.23	0.00	2.05	1.82	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	9.36	28.63	0.00	0.00	0.00	3.67	5.32	0.37	0.00
Macrophage - monocyte derived, donor3	11389-118C3	16.12	19.27	1.70	0.39	0.26	1.84	2.75	0.66	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	10.62	2.12	3.19	1.06	1.06	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	10.62	3.64	5.70	4.44	0.00	0.16	0.00	0.32	0.16
Mallassez-derived cells, donor3	11930-125I4	7.92	5.42	4.86	2.08	0.69	0.28	0.00	0.14	0.14
Mammary Epithelial Cell, donor1	11273-116H4	20.63	15.15	10.36	3.29	0.80	0.40	0.70	0.90	0.20
Mammary Epithelial Cell, donor2	11350-117G9	11.58	8.11	8.11	2.32	0.87	0.87	0.00	0.58	0.00
Mammary Epithelial Cell, donor3	11422-118F9	16.46	7.98	3.24	0.25	1.00	0.00	0.00	0.75	0.00
Mast cell - stimulated, donor1	11487-119E2	20.34	36.61	0.00	0.00	0.00	2.03	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	28.33	29.20	3.35	4.76	0.54	1.19	1.08	0.22	0.00
Mast cell, donor2	11565-120D8	35.36	37.74	6.24	2.38	0.59	1.49	0.89	0.00	0.00
Mast cell, donor3	11566-120D9	35.34	36.47	7.65	2.70	0.23	2.25	1.13	0.45	0.00
Mast cell, donor4	11567-120E1	31.56	31.56	5.85	1.95	0.18	1.60	0.89	0.18	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	30.61	31.49	6.32	5.54	0.22	1.00	2.33	0.44	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	18.09	29.18	2.33	3.50	0.00	5.25	2.92	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	32.70	33.38	4.47	3.56	0.11	1.95	1.61	0.46	0.00
Mast cell, expanded, donor8	11941-126A6	30.96	35.48	4.85	6.36	0.17	2.18	2.68	0.33	0.17
Melanocyte - dark, donor1	11502-119F8	16.72	9.35	5.27	1.39	0.20	0.60	0.60	0.20	0.10
Melanocyte - dark, donor2	11582-120F7	10.38	5.19	4.85	0.00	1.04	0.00	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	15.79	16.01	7.75	1.30	0.72	0.80	0.22	0.36	0.00
Melanocyte - light, donor1	11274-116H5	9.87	7.05	4.94	0.94	1.88	0.24	0.24	0.00	0.00
Melanocyte - light, donor2	11351-117H1	22.52	13.65	7.51	2.05	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	9.54	4.34	0.87	0.87	0.00	0.00	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	11.04	6.35	6.87	0.73	1.25	0.10	0.21	0.31	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	11.03	10.22	4.30	0.81	0.00	0.54	0.00	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	14.46	10.98	5.62	1.34	1.34	0.54	0.00	0.27	0.00
Meningeal Cells, donor1	11493-119E8	16.75	18.24	16.25	2.73	0.99	0.25	0.25	0.12	0.00
Meningeal Cells, donor2	11573-120E7	12.32	9.24	5.72	2.20	1.76	0.00	0.44	0.00	0.00
Meningeal Cells, donor3	11654-122E7	15.97	14.67	11.00	0.98	0.65	0.33	0.24	0.33	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	12.83	14.83	5.70	1.71	0.57	0.57	0.00	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	8.55	2.82	5.53	0.50	0.60	0.20	0.20	0.10	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	7.88	5.26	2.63	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	9.16	7.85	6.54	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	12.20	6.46	7.18	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	9.74	4.02	4.87	0.85	0.42	0.42	0.00	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	10.05	4.02	7.04	0.50	1.01	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	15.60	12.31	9.45	0.22	0.66	0.22	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	16.80	9.50	5.84	1.46	2.19	0.73	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	17.39	11.05	7.37	0.20	0.61	0.61	0.00	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	7.48	5.82	5.68	0.55	0.14	0.42	0.14	0.14	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	8.18	4.09	7.06	0.74	0.74	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	8.95	4.47	5.66	1.05	0.00	0.26	0.00	0.13	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	7.72	5.34	3.86	0.59	0.30	0.89	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	17.93	2.56	7.68	0.64	0.64	0.00	0.00	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	8.51	6.73	4.61	0.00	0.35	0.00	0.00	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	4.69	3.44	6.25	0.31	0.00	0.00	0.31	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	9.43	7.26	8.71	0.73	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	8.75	2.39	2.65	3.71	0.53	0.00	0.00	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	10.51	1.50	6.01	4.00	0.50	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	12.07	1.73	2.67	2.24	0.14	0.22	0.07	0.14	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	21.61	12.15	2.70	0.00	0.00	2.70	4.05	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	16.75	16.99	1.48	0.49	0.25	0.99	2.96	0.49	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	12.07	18.55	0.88	0.88	0.29	2.06	3.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	6.91	0.00	0.00	0.00	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	13.64	10.54	0.62	0.31	0.62	0.31	1.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	10.37	15.97	1.45	1.24	0.21	0.83	1.87	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	4.63	0.00	0.00	0.00	6.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	13.01	15.27	1.75	0.75	0.50	1.00	1.50	0.75	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	13.96	17.22	0.93	1.40	0.47	2.79	3.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47	0.00	0.00	0.00	0.00	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	11.38	16.05	1.42	0.20	0.00	1.22	1.83	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	15.44	16.63	3.17	0.40	0.00	2.38	4.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	11.50	9.73	1.77	0.88	0.00	0.00	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	10.64	15.20	2.28	0.76	0.00	1.90	3.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5.26	5.26	0.00	0.00	0.00	2.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	15.49	12.31	1.06	0.00	0.00	0.42	1.27	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	6.45	8.29	1.84	0.00	0.92	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	10.43	8.94	0.89	0.00	0.00	1.19	0.60	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	6.71	8.38	0.00	0.00	0.00	1.68	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	11.79	12.04	1.51	0.00	0.25	0.75	1.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	13.31	12.36	0.71	0.24	0.00	0.71	1.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	11.06	2.76	0.55	0.00	0.00	0.00	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	11.28	8.98	1.15	0.00	0.46	0.92	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	9.68	9.25	1.89	0.21	0.00	0.42	1.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	9.78	6.52	0.82	0.20	0.00	0.41	0.82	0.41	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	8.80	11.59	0.86	0.00	0.00	0.21	1.07	0.43	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	9.11	10.00	0.67	0.22	0.00	0.67	1.78	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	5.26	7.01	0.44	0.00	0.00	0.88	0.66	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	6.08	6.59	0.51	0.00	0.00	0.00	2.03	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	1.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	7.34	8.70	0.54	0.00	0.00	0.82	1.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	9.41	9.12	0.29	0.00	0.00	0.00	1.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	5.45	3.27	1.09	0.00	0.00	1.09	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	9.61	4.32	0.48	0.00	0.48	0.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	8.40	8.81	1.20	0.00	0.00	0.00	2.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	4.11	2.74	4.11	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	13.02	6.51	3.00	0.00	0.50	0.50	0.00	1.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	26.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	8.15	2.04	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	9.63	7.01	2.19	0.00	0.88	0.00	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	7.73	1.10	0.00	0.00	0.00	0.00	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.04	3.20	1.28	0.00	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	10.66	7.44	1.98	0.00	0.25	0.25	0.50	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	6.26	5.57	0.70	0.00	0.00	0.00	1.39	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	8.84	6.63	2.21	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	12.31	11.28	2.74	0.00	0.34	0.00	0.00	0.68	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	6.56	3.94	0.44	0.00	0.00	0.88	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	5.68	6.75	0.36	0.36	0.00	0.00	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	17.11	9.54	0.28	0.00	0.84	0.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	5.82	8.73	0.83	0.00	0.83	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	11.07	5.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	9.05	11.16	0.30	0.00	0.00	0.60	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	12.10	12.94	0.83	0.00	0.00	0.83	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	9.24	8.31	0.00	0.00	0.00	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	11.38	14.80	0.57	0.00	0.00	0.00	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	11.33	5.67	0.69	0.00	0.28	0.00	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	13.48	11.40	0.78	0.00	0.00	0.00	0.00	0.52	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	4.29	15.01	2.14	0.00	0.00	0.00	0.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.26	4.45	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	16.01	7.47	0.53	0.27	0.00	0.53	0.00	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	11.08	12.87	1.80	0.00	0.30	1.50	1.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	9.89	8.90	0.71	0.00	0.14	0.00	0.42	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	14.33	10.83	1.91	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	12.16	15.48	1.33	0.00	0.22	0.00	0.22	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	14.03	6.83	1.14	0.00	0.76	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	14.77	13.35	1.14	0.00	0.28	0.85	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	12.78	19.17	0.49	0.00	0.00	0.49	0.49	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	17.60	5.87	1.30	0.00	0.00	1.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	16.76	8.53	1.47	0.00	0.00	0.00	0.29	0.88	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	12.40	12.69	1.73	0.00	0.29	0.00	0.58	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	13.19	14.01	0.00	0.00	0.00	0.82	0.82	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	20.84	14.89	0.00	0.30	0.00	1.49	0.30	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	15.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	5.35	8.91	1.78	0.00	1.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	16.10	16.43	1.31	0.00	0.33	0.33	0.00	1.31	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	15.78	16.83	5.26	0.00	0.00	1.05	0.00	2.10	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	16.61	15.22	1.19	0.20	0.00	0.79	0.79	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	13.97	16.76	2.79	0.00	0.00	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	17.65	20.65	3.76	0.00	0.38	0.75	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	13.58	17.05	1.33	0.00	0.00	0.00	0.80	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	14.82	13.46	1.02	0.00	0.23	0.45	0.23	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	13.26	13.26	2.21	0.00	1.47	0.00	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	18.32	16.12	1.10	0.00	0.00	0.37	0.37	1.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	20.22	10.89	0.00	0.00	0.00	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	18.17	28.33	0.53	0.00	0.00	0.00	0.00	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	15.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	17.17	11.11	1.01	0.00	0.00	0.00	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	13.07	12.65	2.53	0.00	0.84	1.26	0.42	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	14.98	19.07	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	8.90	14.62	0.64	0.00	0.64	0.64	1.27	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	8.91	13.77	0.81	0.81	0.00	0.00	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	15.10	13.59	0.00	0.00	0.00	0.00	0.00	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	17.13	5.71	5.71	0.00	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	16.31	9.79	3.26	0.00	3.26	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	28.51	0.00	0.00	0.00	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	0.00	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	10.34	4.74	7.32	0.86	0.00	0.43	0.00	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	12.54	8.88	6.79	0.52	0.00	0.52	0.00	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	9.34	0.67	3.34	0.67	0.67	0.00	0.00	1.33	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	6.68	2.09	2.50	0.83	0.42	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	6.85	4.18	4.94	3.23	0.76	0.57	0.00	0.19	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	9.58	12.77	4.79	1.60	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	4.76	2.04	2.72	0.00	0.00	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	5.51	3.68	11.03	0.00	0.00	1.84	0.00	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	6.28	2.93	1.26	1.26	0.00	0.00	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	5.11	1.16	5.35	0.70	0.23	0.00	0.46	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	12.16	1.89	3.24	0.81	0.54	0.27	0.27	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	13.03	4.41	5.26	0.21	0.21	0.21	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	11.13	33.40	22.27	0.00	0.00	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	6.45	4.96	4.96	0.50	0.50	0.00	0.00	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	3.79	2.98	4.33	0.81	0.00	0.00	0.00	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	4.53	1.13	2.04	0.45	0.68	0.00	0.23	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	6.86	3.27	2.61	1.14	0.00	0.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	7.47	3.65	3.65	1.28	0.18	0.00	0.18	0.36	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	6.90	2.65	5.30	0.53	0.53	0.53	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	7.20	2.40	1.20	0.00	0.00	0.60	0.00	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	6.24	3.28	3.28	1.97	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	3.25	1.95	3.74	0.33	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	9.17	3.70	3.17	0.71	0.18	0.35	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	2.11	1.41	1.41	1.41	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	5.98	1.38	0.92	0.92	0.00	0.00	0.46	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	5.14	1.29	3.86	1.61	0.32	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	2.07	4.83	3.45	4.48	0.00	0.34	0.34	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	20.23	12.64	7.59	7.59	0.00	0.00	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	9.13	3.12	2.45	1.56	0.89	0.45	0.45	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	4.66	0.85	2.54	0.42	0.42	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	4.03	2.85	2.37	0.95	0.00	0.24	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	9.87	2.58	3.43	0.00	0.00	0.00	0.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	9.03	27.08	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	6.66	2.67	3.33	0.00	0.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	10.37	2.71	1.80	0.45	0.00	0.45	0.00	0.45	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	4.76	1.59	3.97	1.59	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	4.64	2.79	1.86	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	4.92	1.89	5.68	1.14	0.38	0.38	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	4.89	2.28	3.91	0.65	0.33	0.00	0.00	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	10.89	1.31	2.18	0.44	0.00	0.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	11.31	0.90	4.52	1.81	0.00	0.00	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.06	4.41	5.29	0.88	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	6.65	2.66	2.66	0.66	0.66	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	12.40	4.46	1.49	0.00	0.99	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	3.83	2.68	3.83	0.38	0.00	0.38	0.77	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	6.65	4.23	7.56	3.63	0.00	0.00	0.60	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	5.97	3.98	4.86	0.66	0.00	0.22	0.22	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	7.45	2.03	2.03	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	0.00	5.11	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	9.15	2.44	2.44	0.61	0.61	1.22	0.61	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	4.72	0.94	1.89	0.94	0.00	0.00	0.31	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	9.08	0.91	3.33	0.61	0.30	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	6.33	0.79	1.58	0.79	0.00	0.00	0.00	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	6.80	3.40	1.13	6.80	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	10.12	15.17	5.06	0.00	0.00	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	7.70	3.98	4.60	0.75	0.00	0.00	0.25	0.12	0.00
Myoblast, donor2	11322-117D8	8.06	6.90	5.18	0.58	0.00	0.19	0.19	0.38	0.00
Myoblast, donor3	11398-118D3	6.22	6.56	6.89	1.51	0.17	0.34	0.00	0.17	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	16.93	9.05	7.30	1.90	0.88	0.58	0.44	0.44	0.00
Natural Killer Cells, donor1	11230-116C6	22.14	17.84	9.53	4.00	0.31	0.92	1.54	1.54	0.00
Natural Killer Cells, donor2	11311-117C6	15.38	15.38	6.63	1.81	0.30	1.51	0.60	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	18.59	16.75	12.15	4.23	0.74	2.02	1.47	0.92	0.00
Neural stem cells, donor1	11275-116H6	30.12	25.41	7.62	5.44	0.00	0.73	0.00	0.00	0.00
Neural stem cells, donor2	11352-117H2	15.41	21.18	5.78	9.63	0.00	0.00	1.93	0.00	0.00
Neurons, donor1	11494-119E9	27.31	28.45	9.10	3.41	1.14	1.14	0.00	3.41	0.00
Neurons, donor2	11574-120E8	29.28	17.83	9.03	6.83	0.88	0.44	0.22	1.54	0.00
Neurons, donor3	11655-122E8	29.60	23.84	2.47	3.29	0.00	0.00	0.82	3.29	0.00
Neutrophils, donor1	11233-116C9	64.03	58.46	2.78	0.00	0.93	17.63	10.21	0.93	0.00
Neutrophils, donor2	11314-117C9	40.58	49.28	0.00	0.00	0.00	5.80	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	85.52	69.03	6.72	0.00	1.22	6.72	12.83	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	14.37	13.06	6.89	0.95	0.36	0.36	0.36	0.36	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	15.95	6.84	2.28	0.98	0.33	0.65	0.33	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	8.62	5.82	4.81	0.20	0.20	0.00	0.00	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	7.71	2.75	4.54	0.83	0.14	0.14	0.14	0.28	0.00
Olfactory epithelial cells, donor2	11934-125I8	8.40	4.20	4.05	1.45	0.14	0.00	0.29	0.43	0.00
Olfactory epithelial cells, donor3	11935-125I9	9.31	3.41	6.36	1.93	0.23	0.11	0.00	0.68	0.00
Olfactory epithelial cells, donor4	11936-126A1	8.67	2.43	4.29	1.27	0.39	0.19	0.58	0.10	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	13.24	5.42	4.81	2.41	1.81	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	14.04	5.10	7.66	0.43	0.43	0.43	0.43	0.43	0.00
Osteoblast - differentiated, donor2	11353-117H3	8.00	1.14	6.86	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	10.55	8.69	5.59	1.86	0.62	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	19.74	9.77	7.43	1.76	0.39	0.59	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	20.37	11.24	7.73	0.00	1.40	0.00	0.70	0.70	0.70
Osteoblast, donor3	11426-118G4	16.53	8.00	4.27	0.89	0.18	0.00	0.00	0.53	0.00
Pancreatic stromal cells, donor1	11249-116E7	14.83	8.42	4.80	2.02	0.08	0.34	0.00	0.25	0.00
Pericytes, donor1	11491-119E6	10.46	13.91	9.90	1.22	0.56	0.56	0.11	0.00	0.00
Pericytes, donor2	11571-120E5	11.54	12.90	8.60	2.49	1.36	0.00	0.00	0.45	0.23
Pericytes, donor3	11652-122E5	8.95	5.29	5.09	0.61	1.02	0.20	0.20	0.20	0.00
Perineurial Cells, donor1	11499-119F5	10.74	5.20	6.44	1.92	0.57	0.23	0.23	0.00	0.00
Perineurial Cells, donor2	11579-120F4	13.25	9.94	4.14	2.21	0.46	0.00	0.09	0.37	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	32.83	33.79	9.88	1.59	0.64	2.87	3.19	0.64	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	27.18	19.34	6.12	1.22	0.24	1.47	2.45	1.22	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	24.20	21.22	5.44	1.55	0.26	1.04	2.07	0.78	0.00
Placental Epithelial Cells, donor1	11278-116H9	15.55	5.26	7.89	0.48	1.67	0.00	0.00	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	11.09	1.11	5.54	4.44	1.11	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	20.22	7.66	5.30	3.34	1.18	0.20	0.39	0.59	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	9.81	3.16	1.90	0.00	0.32	0.00	0.32	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	11.63	4.50	5.25	1.31	0.38	0.00	0.19	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	18.27	4.83	6.27	1.83	0.39	0.13	0.13	0.26	0.00
Preadipocyte - breast, donor2	11328-117E5	10.36	5.85	2.93	2.25	0.68	0.00	0.00	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	14.49	3.41	4.80	1.28	0.32	0.32	0.00	0.11	0.11
Preadipocyte - omental, donor2	11329-117E6	12.66	4.80	3.06	2.18	0.00	0.00	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	12.46	4.30	4.58	1.72	0.43	0.00	0.14	0.14	0.00
Preadipocyte - perirenal, donor1	11469-119C2	4.92	0.00	4.92	0.98	0.98	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	16.28	8.60	8.91	0.31	0.61	0.31	0.00	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	17.00	11.86	7.97	0.18	0.00	0.18	0.00	0.53	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	10.39	5.62	5.62	0.34	0.34	0.34	0.00	0.51	0.00
Preadipocyte - visceral, donor1	11280-116I2	15.65	11.64	7.27	1.02	0.47	0.00	0.19	0.28	0.00
Preadipocyte - visceral, donor2	11357-117H7	14.27	4.14	5.52	0.92	0.00	0.00	0.00	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	10.76	7.52	4.81	0.21	0.21	0.00	0.00	0.42	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	8.15	10.26	3.47	6.79	0.45	0.60	0.45	0.15	0.00
Prostate Epithelial Cells, donor2	11331-117E8	5.42	1.35	4.87	1.62	0.14	0.14	0.00	0.00	0.00
Prostate Epithelial Cells, donor3	11404-118D9	8.08	2.20	5.27	0.67	1.16	0.06	0.06	0.31	0.00
Prostate Stromal Cells, donor1	11254-116F3	12.30	5.24	4.90	0.68	0.11	0.23	0.11	0.46	0.00
Prostate Stromal Cells, donor2	11332-117E9	12.19	4.66	6.10	1.08	0.36	0.00	0.18	0.36	0.00
Prostate Stromal Cells, donor3	11405-118E1	8.24	4.07	5.01	0.63	0.00	0.10	0.10	0.52	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	13.50	6.57	13.87	1.09	1.82	0.36	0.00	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	8.25	3.40	6.72	0.97	0.62	0.07	0.00	0.28	0.07
Renal Epithelial Cells, donor1	11517-119H5	14.71	7.10	13.19	1.01	0.51	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	17.78	4.27	7.82	1.42	1.42	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	10.37	4.34	8.47	1.16	0.00	0.21	0.11	0.21	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	12.94	5.45	2.04	0.00	0.00	0.00	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	11.05	5.53	5.79	0.94	0.67	0.40	0.13	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	13.76	4.88	7.33	0.67	1.33	0.22	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	11.98	3.33	4.66	0.00	0.67	0.67	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	12.77	11.22	14.31	2.20	0.66	0.00	0.22	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	15.05	3.76	8.15	3.76	0.00	0.00	0.00	1.25	0.00
Renal Mesangial Cells, donor3	11679-122H5	13.32	6.10	6.10	0.83	0.55	0.00	0.55	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	15.57	8.86	12.62	1.07	0.54	0.54	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	11.39	5.06	4.64	0.42	1.69	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	16.58	7.71	8.49	1.74	1.35	0.00	0.19	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	13.74	10.37	7.26	2.07	0.78	0.00	0.00	1.04	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	16.77	9.66	12.79	2.56	0.28	0.28	0.00	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	12.35	7.20	6.17	1.03	0.00	0.00	0.00	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	10.04	6.52	9.03	1.51	0.50	0.00	0.25	0.50	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	32.61	16.44	9.76	12.03	1.07	0.53	0.27	1.07	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	20.55	8.93	6.25	0.00	0.00	0.89	0.00	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	24.22	11.56	6.05	0.00	0.00	0.55	0.00	1.10	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	21.46	7.54	6.96	0.00	1.16	1.16	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	11.96	8.32	7.28	0.52	0.78	0.26	0.13	0.52	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	17.48	7.65	5.26	0.00	0.60	0.10	0.10	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	24.32	10.37	7.58	0.11	0.45	0.56	0.22	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	16.25	9.68	7.81	0.37	0.37	0.00	0.00	0.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	17.48	9.67	5.83	0.12	1.52	0.12	0.23	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	22.42	8.09	6.01	0.46	1.16	0.23	0.00	0.69	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	13.42	5.48	4.79	0.00	0.68	0.14	0.00	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	19.36	8.93	5.60	0.61	0.15	0.00	0.15	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	19.53	8.24	6.45	0.18	0.54	0.72	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	13.48	7.32	8.46	0.43	0.43	0.00	0.29	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	17.81	7.51	6.22	0.21	0.32	0.21	0.11	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	20.80	11.28	6.20	0.00	0.66	0.44	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	13.76	6.50	5.35	0.00	0.57	0.38	0.00	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	17.89	7.36	5.78	0.19	0.84	0.09	0.00	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	25.18	9.58	11.09	0.19	0.00	0.19	0.19	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	12.61	8.10	5.71	0.13	1.59	0.27	0.27	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	19.66	6.13	6.42	0.19	0.88	0.29	0.00	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	20.81	7.45	5.92	0.00	0.57	0.19	0.19	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	13.03	6.94	6.41	0.21	0.75	0.11	0.00	0.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	17.66	7.29	3.36	0.00	0.00	0.00	0.00	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	22.56	6.32	8.54	0.17	0.51	0.68	0.00	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	10.76	6.02	6.56	0.00	0.91	0.36	0.00	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	17.41	7.97	6.50	0.12	0.12	0.12	0.12	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	22.43	8.33	6.45	0.13	0.81	0.13	0.27	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	12.74	11.79	8.96	0.24	1.18	0.47	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	18.06	5.95	7.34	0.00	0.40	0.00	0.00	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	22.68	10.29	6.55	0.23	0.47	0.00	0.23	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	15.34	7.46	6.01	0.00	1.45	0.21	0.21	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	20.13	8.85	6.42	0.22	0.22	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	19.64	7.94	8.15	0.00	0.63	0.42	0.21	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	13.86	8.21	8.21	0.13	0.54	0.27	0.00	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	16.01	7.15	4.94	0.00	0.34	0.51	0.17	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	19.67	8.10	6.17	0.19	1.16	0.19	0.39	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	14.44	9.63	10.32	0.17	0.34	0.17	0.00	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	16.60	7.13	5.76	0.27	1.10	0.27	0.00	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	20.03	6.90	7.22	0.16	0.16	0.33	0.16	0.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	12.27	5.79	5.79	0.34	0.51	0.00	0.34	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	20.86	10.21	5.03	0.15	0.59	0.00	0.00	0.59	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	15.19	9.33	4.80	0.00	1.07	0.53	0.27	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	13.41	10.65	5.81	0.14	1.38	0.28	0.14	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	22.62	7.62	4.29	0.24	1.19	0.24	0.24	0.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	25.80	11.29	6.25	0.40	0.60	0.40	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	14.79	10.74	7.06	0.00	0.66	0.19	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	28.65	13.97	9.08	0.00	0.35	0.70	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	33.55	9.97	4.23	0.00	0.60	0.30	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	11.14	8.32	6.24	0.12	0.12	0.37	0.12	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	40.61	13.10	7.28	1.02	0.58	2.18	0.73	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	33.46	4.26	6.69	0.00	0.00	0.00	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	16.88	8.14	5.43	0.30	0.00	0.30	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	27.14	13.35	5.43	0.00	0.00	0.45	0.45	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	23.36	12.88	5.69	0.30	0.60	1.50	0.60	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	19.48	13.46	4.84	0.24	0.94	0.83	0.35	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	20.92	11.95	5.34	0.43	0.64	0.64	0.21	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	19.83	9.62	6.61	0.00	0.00	1.80	0.60	0.60	0.00
Schwann Cells, donor1	11498-119F4	13.73	11.47	8.84	1.32	0.75	0.19	0.38	0.19	0.00
Schwann Cells, donor2	11578-120F3	13.61	6.80	3.40	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	8.33	8.54	6.57	1.53	0.88	0.00	0.00	0.44	0.00
Sebocyte, donor1	11220-116B5	15.34	6.57	3.83	1.10	0.55	0.00	1.10	0.00	0.00
Sebocyte, donor2	11301-117B5	14.71	5.06	6.43	1.84	0.46	0.46	0.00	0.46	0.00
Sebocyte, donor3	11378-118B1	13.40	4.33	5.15	1.44	0.41	0.00	0.41	0.41	0.00
Sertoli Cells, donor1	11255-116F4	21.54	4.97	3.31	4.97	0.00	1.66	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	14.12	8.47	2.82	0.00	0.00	0.00	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	16.98	9.85	8.01	2.46	0.79	0.00	0.09	0.53	0.00
Skeletal Muscle Cells, donor2	11358-117H8	18.07	7.95	10.84	0.72	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	20.06	17.56	6.69	0.84	0.00	0.84	0.84	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	10.53	7.38	5.81	1.57	1.10	0.00	0.16	0.79	0.00
Skeletal Muscle Cells, donor5	11455-119A6	10.70	8.32	5.50	1.04	0.45	0.59	0.00	0.30	0.00
Skeletal Muscle Cells, donor6	11459-119B1	12.47	8.16	6.00	0.92	1.54	0.46	0.00	0.62	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	14.99	12.22	4.66	4.03	0.38	0.63	0.13	0.25	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	10.84	8.56	4.00	2.43	0.29	0.29	0.14	0.43	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	16.67	8.43	7.04	1.49	1.39	0.30	0.40	0.50	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	20.73	10.53	9.35	2.61	0.76	0.42	0.08	0.67	0.42
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	18.09	9.41	5.79	0.00	0.72	0.72	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	10.04	8.53	4.68	0.69	1.10	0.41	0.28	0.28	0.14
Skin - palm, donor1	10286-104F7	24.17	13.43	5.37	2.69	2.69	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	5.33	2.59	3.32	0.29	0.14	0.00	0.00	0.29	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	14.72	5.73	15.54	12.27	0.82	1.64	2.45	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	5.97	4.67	2.99	0.26	0.26	0.00	0.00	0.39	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	8.20	4.31	5.98	2.36	0.42	0.14	0.00	0.28	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	11.96	2.67	2.95	0.98	0.42	0.14	0.00	0.14	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	16.70	7.19	6.34	16.92	0.21	0.85	1.90	0.63	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	11.09	3.07	3.67	1.12	0.30	0.15	0.15	0.15	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	8.64	4.01	4.63	0.62	0.93	0.00	0.00	0.62	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	7.34	1.33	3.56	0.89	0.22	0.67	0.67	0.44	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	12.93	4.11	5.29	0.00	0.59	0.00	0.00	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	13.26	6.85	3.54	1.10	0.44	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	10.24	4.33	7.09	0.79	0.00	0.00	0.00	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	10.82	6.95	6.18	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	12.01	11.01	7.01	1.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	10.51	6.25	5.59	0.27	0.40	0.00	0.13	0.40	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	6.43	3.77	3.55	0.44	0.22	0.44	0.22	0.66	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	4.99	3.20	5.51	0.77	0.64	0.90	0.00	0.26	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	12.05	6.19	5.21	0.98	0.98	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	13.88	4.73	6.50	1.48	0.59	0.00	0.59	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	8.40	1.99	4.41	0.85	0.14	0.14	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	9.60	5.53	7.48	0.49	0.65	0.00	0.00	0.33	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	7.00	4.87	4.87	1.22	1.22	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	10.86	5.56	4.80	0.25	0.76	0.25	0.25	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	0.00	6.12	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	10.49	3.34	1.43	0.00	1.91	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	8.85	3.54	3.83	1.77	0.44	0.15	0.15	0.00	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	8.82	2.58	5.17	1.08	0.22	0.43	0.00	0.43	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	10.39	5.04	5.25	1.68	0.42	0.00	0.00	0.31	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	10.36	4.49	6.03	0.00	0.31	0.31	0.15	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	5.39	1.08	4.31	0.00	0.00	1.08	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	11.36	3.59	1.79	0.00	0.30	0.60	0.00	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	16.05	2.39	10.92	0.00	0.34	0.34	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	10.52	8.01	4.71	2.75	0.08	0.39	0.00	0.39	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	8.35	5.23	6.34	1.01	0.40	0.50	0.00	0.30	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	16.61	5.46	5.01	0.00	0.68	0.46	0.23	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	8.45	1.81	6.04	0.60	0.00	0.00	0.00	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	21.46	9.80	12.45	0.00	1.59	0.53	0.00	0.79	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	6.52	5.73	5.59	1.07	0.67	0.67	0.00	0.53	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	8.01	4.88	3.51	2.00	0.25	0.25	0.25	0.38	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	8.62	9.64	5.07	1.01	0.25	0.51	0.00	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	13.87	8.14	6.94	0.75	0.45	0.45	0.30	0.30	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	9.00	6.75	6.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	21.97	25.84	3.88	7.75	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	17.21	6.98	8.84	0.93	0.00	0.00	0.47	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	8.58	4.04	6.06	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	9.72	2.19	5.33	0.00	0.00	0.63	0.00	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	7.37	5.90	5.01	1.18	0.00	0.29	0.29	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	16.08	12.50	7.33	1.00	0.67	0.25	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	12.15	5.61	3.27	0.93	0.93	0.00	0.00	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	10.22	2.73	4.75	0.43	0.86	0.29	0.43	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	13.77	4.33	3.82	0.00	0.76	0.76	0.25	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	12.60	6.39	4.51	0.38	0.38	0.38	0.38	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	13.42	7.83	5.45	1.26	0.28	0.14	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	9.47	2.93	4.19	0.50	0.50	0.17	0.08	0.17	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	5.24	0.95	4.76	0.00	0.00	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	7.58	1.71	3.67	0.00	0.24	0.00	0.24	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	8.40	6.41	6.19	1.10	0.44	0.66	0.22	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	11.70	7.02	6.73	0.00	0.29	0.59	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	4.66	3.11	3.30	0.19	0.00	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	8.46	3.44	4.50	1.32	0.00	0.79	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	2.98	4.46	1.86	2.98	0.00	0.74	0.00	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	7.19	4.31	6.83	0.36	0.00	0.00	0.36	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	7.10	3.12	5.96	1.99	0.00	0.28	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	13.79	5.91	7.48	1.58	0.39	0.00	0.00	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	4.83	3.81	1.52	0.51	0.25	0.00	0.51	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	5.99	5.19	3.59	1.20	0.00	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	3.76	2.09	5.43	1.25	0.00	0.42	0.84	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	6.88	3.21	5.04	1.83	0.00	0.92	0.00	0.92	0.00
Synoviocyte, donor1	11291-117A4	13.30	4.88	5.05	0.17	0.00	0.17	0.17	0.17	0.00
Synoviocyte, donor2	11368-117I9	10.06	4.02	3.02	0.17	0.67	0.17	0.00	0.50	0.00
Synoviocyte, donor3	11440-118H9	7.82	4.24	4.02	0.67	0.89	0.22	0.45	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	20.01	13.94	11.79	1.79	2.50	0.00	0.36	0.71	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	15.86	3.96	7.93	0.00	0.00	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	22.23	8.80	7.18	1.62	0.46	0.46	0.00	0.46	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	10.82	3.73	5.09	1.36	0.29	0.29	0.07	0.07	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	10.44	4.64	4.25	0.00	0.77	0.00	0.39	1.16	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	7.44	8.59	2.29	0.57	0.57	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	30.26	14.27	11.69	12.18	0.74	0.74	1.23	0.49	0.00
Urethra, donor2	10319-105A4	34.17	10.79	7.19	1.80	0.00	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	5.84	1.86	5.58	0.27	0.53	0.00	0.00	0.27	0.00
Urothelial Cells, donor2	11600-120H7	8.01	2.80	5.21	1.20	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	4.81	3.67	3.67	0.69	0.23	0.00	0.00	0.23	0.00
Urothelial cells, donor0	11216-116B1	7.13	2.01	3.57	0.89	0.45	0.22	0.45	0.45	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	31.14	37.37	18.69	1.78	2.67	9.79	2.67	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	61.47	50.04	10.01	2.86	0.00	10.01	14.30	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	18.48	35.60	7.53	1.37	0.68	6.16	4.11	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	37.88	35.12	13.77	5.17	0.34	3.10	3.79	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	47.06	41.83	13.36	4.65	0.00	6.39	5.23	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	35.40	45.81	12.49	7.29	0.00	12.49	10.41	3.12	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	36.71	44.05	17.44	4.59	0.92	5.51	4.59	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	36.52	22.82	8.22	0.00	0.91	4.56	2.74	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	13.08	10.12	9.87	3.82	1.11	1.73	0.99	0.25	0.12
Wilms' tumor cell line:HFWT	10597-108E3	19.36	5.28	1.76	4.40	0.88	0.88	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	22.07	6.98	5.59	2.23	0.28	0.00	0.00	0.00	0.00
achilles tendon, donor2	10292-104G4	12.40	16.53	6.20	0.00	0.00	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	22.44	31.36	8.92	5.10	1.02	1.78	1.27	0.51	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	41.33	24.84	11.14	1.86	0.23	0.93	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	26.71	21.84	13.53	9.02	1.31	0.71	0.36	0.36	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	47.62	52.52	13.33	0.00	1.09	1.09	0.27	0.82	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	19.96	18.27	2.53	1.97	0.28	0.00	0.84	0.56	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	28.97	22.63	2.54	2.75	0.42	3.17	3.17	0.63	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	26.13	34.03	4.36	2.45	0.82	1.63	1.36	0.54	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	20.27	16.74	4.41	3.53	0.44	0.88	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	35.94	13.88	0.82	0.00	0.00	0.82	2.45	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	46.21	24.85	5.44	0.00	0.39	0.78	1.94	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	24.10	25.94	2.94	1.66	0.18	0.37	0.18	0.55	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	35.10	27.30	3.90	0.00	0.00	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	27.89	39.50	3.25	0.00	0.23	2.32	0.93	0.46	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	28.22	15.28	6.99	3.88	0.78	0.00	0.26	0.52	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	34.19	30.39	2.34	6.43	0.29	0.29	0.00	0.58	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	20.91	10.69	2.32	4.18	0.00	3.25	4.65	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	33.31	12.34	3.70	0.00	0.41	0.82	0.41	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	513.83	147.34	80.42	0.00	7.06	2.15	2.46	3.68	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	655.85	378.06	85.77	0.00	9.39	7.25	11.09	14.08	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	616.90	380.33	77.64	0.00	8.80	9.40	9.10	14.25	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	686.73	425.33	94.60	0.00	9.39	10.11	10.11	10.83	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	26.73	26.95	5.57	0.22	0.45	0.00	0.45	0.89	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	31.02	23.68	8.67	0.67	0.67	3.00	3.00	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	31.59	7.43	5.57	1.86	0.00	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	70.06	53.86	16.20	5.65	2.26	4.14	1.88	2.26	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	53.64	54.52	2.62	5.23	0.00	3.93	0.87	2.18	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	33.74	13.12	11.25	3.75	0.00	5.62	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	29.91	3.77	4.95	5.89	0.71	0.47	0.47	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	25.44	16.13	10.08	1.09	0.62	0.47	0.16	0.47	0.00
adipose, donor1	10184-103D4	5.86	21.70	19.35	43.39	1.17	0.00	0.00	0.00	0.59
adipose, donor2	10185-103D5	4.46	10.14	6.49	8.11	0.00	0.41	0.81	0.41	0.00
adipose, donor3	10186-103D6	10.89	15.25	8.17	16.07	0.82	0.54	0.00	0.54	0.27
adipose, donor4	10187-103D7	21.67	13.00	7.80	32.07	0.00	0.00	0.00	0.00	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	45.45	20.52	9.47	2.68	2.53	0.63	0.47	0.00	0.32
adrenal gland, adult, pool1	10081-102A9	10.91	7.28	7.28	3.64	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	36.02	30.42	15.07	3.34	2.13	0.53	0.93	0.93	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	31.09	8.58	16.08	1.79	1.43	0.71	0.36	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	18.08	3.25	7.88	1.16	1.85	0.23	0.23	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	15.89	6.76	15.21	10.48	1.01	0.00	0.34	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	12.08	3.24	10.02	1.77	0.59	0.29	0.29	0.29	0.00
amygdala - adult, donor10196	10167-103B5	14.23	13.04	5.93	1.19	1.19	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	23.12	13.99	8.52	6.08	0.41	2.43	1.62	0.41	0.00
amygdala, newborn, donor10223	10360-105E9	14.85	14.52	6.78	3.87	0.65	2.26	0.65	0.32	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	17.57	7.39	7.26	1.53	0.64	0.00	0.13	0.25	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	22.50	7.28	9.71	0.00	1.10	0.00	0.22	0.22	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	29.73	20.04	4.68	29.40	1.00	2.00	1.34	0.00	0.67
aorta, adult, pool1	10052-101G7	21.57	12.94	8.63	2.35	0.39	0.78	0.20	0.20	0.00
appendix, adult	10189-103D9	48.51	20.96	13.58	9.31	1.16	1.55	2.33	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	22.01	18.23	14.45	0.00	0.34	0.69	0.00	0.34	0.00
artery, adult	10190-103E1	33.97	13.59	10.87	6.79	2.72	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	24.05	8.98	3.48	3.62	0.58	0.14	0.43	0.00	0.00
b cell line:RPMI1788	10427-106D4	29.15	16.80	11.90	9.52	0.59	0.89	0.30	0.74	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	10.27	3.33	4.72	0.00	0.00	0.28	0.55	0.55	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	17.86	12.90	7.94	2.38	1.09	0.40	0.40	0.10	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	16.91	5.86	4.18	1.00	0.33	0.17	0.17	0.17	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	27.96	36.91	1.12	0.00	0.56	0.56	1.68	0.00	0.00
bladder, adult, pool1	10011-101C2	18.79	9.02	10.21	3.04	0.43	0.22	0.54	0.33	0.00
blood, adult, pool1	10053-101G8	13.29	17.72	2.21	4.43	0.00	0.00	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	16.27	3.43	3.43	1.71	3.43	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	24.97	10.80	10.12	0.67	0.00	0.67	2.70	0.67	0.00
brain, adult, donor1	10084-102B3	25.63	19.48	8.20	3.08	0.00	2.05	4.10	0.00	0.00
brain, adult, pool1	10012-101C3	21.38	13.36	10.24	4.79	0.78	1.34	1.00	0.45	0.00
brain, fetal, pool1	10085-102B4	32.06	37.40	2.67	10.69	2.67	2.67	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	18.83	11.56	10.24	0.00	0.66	0.99	0.66	0.33	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	24.71	9.24	11.48	0.00	1.50	0.12	0.37	0.25	0.00
breast, adult, donor1	10080-102A8	16.42	5.68	9.47	0.00	0.63	0.00	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	21.09	6.10	5.08	1.91	0.76	0.64	0.76	0.51	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	29.69	12.68	4.64	3.71	0.31	0.62	0.00	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	15.42	24.63	11.05	0.00	0.23	0.46	0.69	1.15	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	31.23	23.48	14.28	0.73	0.97	3.15	2.91	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	14.11	12.69	15.05	0.94	3.29	0.00	0.00	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	34.13	27.45	9.63	10.61	2.41	1.53	0.44	0.66	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	17.11	21.55	9.19	1.27	2.54	0.32	0.63	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	31.41	22.63	21.03	4.26	1.86	0.53	1.06	0.27	0.00
caudate nucleus - adult, donor10196	10177-103C6	14.97	19.57	2.30	2.30	2.30	1.15	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	21.59	12.88	8.53	6.02	0.67	3.18	1.51	0.33	0.17
caudate nucleus, adult, donor10258	10379-105H1	22.16	11.46	16.81	4.58	0.00	2.29	3.82	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	33.33	13.18	5.86	5.49	0.37	0.37	0.37	1.10	0.00
cerebellum - adult, donor10196	10173-103C2	20.39	14.57	26.22	2.91	0.00	2.91	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	30.32	23.91	29.25	15.37	2.35	2.78	1.71	0.64	0.00
cerebellum, adult, pool1	10083-102B2	15.18	21.04	14.49	5.17	1.72	0.00	2.07	0.69	0.00
cerebellum, newborn, donor10223	10357-105E6	39.02	41.51	19.10	19.93	0.00	3.32	0.83	0.83	0.00
cerebral meninges, adult	10188-103D8	14.88	11.09	6.81	2.77	0.50	0.76	0.25	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	10.96	8.77	8.77	2.19	0.00	0.73	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	21.42	13.08	10.78	0.00	1.01	0.58	0.29	0.14	0.00
cervical cancer cell line:ME-180	10553-107I4	28.34	9.28	6.63	7.46	1.66	0.83	0.50	0.50	0.00
cervix, adult, pool1	10013-101C4	28.03	17.95	14.28	3.25	0.73	1.36	0.52	0.42	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	23.13	5.99	10.03	0.00	0.84	0.42	0.14	0.28	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	18.29	3.92	2.61	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	26.72	21.00	18.52	12.80	2.61	0.99	0.62	0.25	0.00
choriocarcinoma cell line:SCH	10785-110H2	40.17	15.16	8.75	18.61	2.46	0.49	0.62	0.37	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	28.94	16.37	13.04	2.37	1.42	0.95	0.24	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	15.10	7.12	5.98	2.28	1.14	0.00	0.28	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	13.92	6.26	7.76	4.08	1.89	0.10	0.10	0.30	0.10
chorionic membrane cells, donor3	12240-129G8	18.13	12.64	4.40	4.40	0.55	1.10	0.55	1.10	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	19.19	24.24	5.05	4.04	1.01	1.01	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	24.20	20.17	4.23	0.00	0.38	0.58	0.77	0.19	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	31.47	31.04	1.90	2.53	0.00	1.90	1.90	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	22.86	11.56	12.58	4.88	0.00	0.77	0.26	0.51	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	17.42	17.90	14.75	7.01	0.97	0.48	0.24	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	19.34	14.25	10.59	3.87	0.81	0.00	1.02	0.41	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	17.67	12.07	11.48	2.36	0.29	0.00	0.00	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	40.40	31.54	7.30	7.04	0.52	1.56	0.52	0.52	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	48.46	20.57	6.86	0.00	0.23	0.69	0.46	2.06	0.00
clear cell carcinoma cell line:TEN	10636-108I6	14.92	7.46	10.24	4.16	0.52	0.17	0.00	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	10.25	14.64	5.13	5.13	0.73	0.92	0.18	0.37	0.00
colon carcinoma cell line:COLO-320	10420-106C6	34.59	14.44	7.98	20.90	0.76	0.00	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	19.04	9.52	8.33	10.71	0.00	0.00	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	25.03	13.51	9.28	9.17	0.82	0.24	0.24	0.00	0.00
colon, fetal, donor1	10070-101I7	22.87	11.74	11.12	8.03	0.62	0.62	0.62	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	45.84	13.75	27.50	9.17	0.00	4.58	9.17	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	45.04	26.35	19.97	1.70	0.42	1.27	0.85	0.85	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	19.17	16.75	8.15	3.47	0.60	1.06	1.06	0.15	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	23.83	20.73	9.59	1.69	0.00	0.71	1.41	0.14	0.14
corpus callosum, adult, pool1	10042-101F6	26.31	23.55	15.59	6.41	1.22	2.32	2.76	0.33	0.00
cruciate ligament, donor2	10295-104G7	31.61	20.26	9.73	4.86	1.62	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	21.67	20.06	8.83	7.22	0.80	0.80	0.00	1.61	0.00
diencephalon, adult	10193-103E4	14.64	10.08	9.60	1.68	0.48	0.72	0.48	0.96	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	28.70	19.98	6.43	3.90	0.46	0.69	0.00	0.92	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	53.08	31.29	10.00	0.77	0.51	1.54	1.03	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	5.78	6.50	6.74	1.93	0.48	0.96	0.00	0.00	0.00
ductus deferens, adult	10196-103E7	22.92	11.96	11.46	6.48	0.50	1.00	0.50	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	27.36	20.16	10.08	5.76	1.44	4.32	2.88	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	21.33	25.01	10.30	10.30	0.00	2.21	2.94	0.74	0.00
dura mater, adult, donor1	10041-101F5	21.39	19.24	5.62	0.99	0.91	0.25	0.25	0.25	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	37.53	17.32	38.64	13.32	3.55	2.22	3.55	0.89	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	30.09	12.04	29.95	4.16	1.15	0.57	0.14	0.29	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	25.90	7.40	1.85	0.00	0.62	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	21.19	4.54	5.75	0.61	1.51	0.00	0.00	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	24.70	4.32	4.94	0.00	0.62	0.00	0.93	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	18.39	11.82	10.51	0.00	0.00	1.31	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	16.09	4.02	4.02	3.69	0.67	0.00	0.34	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	42.23	13.59	9.42	0.54	1.09	0.00	0.00	0.18	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	16.24	8.68	4.66	2.57	0.48	0.64	0.00	0.00	0.16
epidermoid carcinoma cell line:A431	10426-106D3	30.68	11.23	8.34	0.67	0.89	1.00	0.22	0.11	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	23.32	2.97	10.89	4.51	1.32	0.55	0.33	0.88	0.00
epididymis, adult	10197-103E8	23.23	15.70	8.79	6.49	0.21	0.42	0.84	0.84	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	22.89	6.03	12.60	2.31	0.89	0.35	0.35	0.18	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	6.29	5.51	4.72	0.79	0.00	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	21.75	10.88	16.38	0.00	1.83	0.26	0.26	1.31	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	25.29	13.39	14.07	0.00	1.18	0.30	0.30	0.59	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	22.29	12.32	14.23	0.00	0.90	0.11	0.22	1.68	0.00
esophagus, adult, pool1	10015-101C6	18.58	9.03	9.56	3.61	0.74	0.53	0.21	0.42	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	16.28	22.29	11.40	4.26	1.25	1.00	0.63	0.50	0.13
eye - muscle inferior rectus, donor1	10272-104E2	14.49	7.24	12.07	4.83	2.41	0.00	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	44.19	18.94	6.31	10.52	0.00	0.00	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	41.67	2.98	16.37	7.44	0.00	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	28.66	17.20	6.88	6.88	2.29	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	11.66	7.29	1.46	2.91	0.00	2.91	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	30.00	20.85	8.64	3.05	1.27	1.02	0.00	0.76	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	26.16	8.08	3.97	0.51	0.51	0.13	0.38	0.38	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	26.12	20.89	10.68	1.42	1.19	0.71	0.24	1.42	0.00
frontal lobe, adult, pool1	10040-101F4	24.96	23.64	11.26	7.69	1.50	3.75	2.06	0.38	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	33.63	6.91	10.21	9.91	0.90	0.60	0.60	0.30	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	10.97	3.93	5.49	0.00	0.37	0.09	0.27	0.00	0.00
gall bladder, adult	10198-103E9	20.28	12.55	9.42	2.17	0.48	0.97	0.72	0.48	0.00
gamma delta positive T cells, donor1	11937-126A2	26.84	17.18	23.62	6.44	1.07	2.15	0.00	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	26.14	17.18	17.55	2.99	0.37	1.49	1.12	1.12	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	20.49	5.49	10.77	3.17	0.84	0.21	0.42	0.84	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	32.11	18.37	8.32	3.09	2.13	0.58	0.58	0.19	0.00
gastric cancer cell line:AZ521	10549-107H9	39.35	14.76	14.26	6.23	2.30	1.48	0.66	0.66	0.49
gastric cancer cell line:GSS	10560-108A2	13.73	5.49	10.07	0.92	0.00	0.92	0.00	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	46.15	37.01	9.14	0.00	1.14	1.83	0.69	0.69	0.00
giant cell carcinoma cell line:LU65	10487-107B1	11.24	3.44	3.56	0.11	0.46	0.11	0.00	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	10.36	3.08	9.66	3.36	0.70	0.14	0.14	0.42	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	42.40	13.97	7.98	1.00	1.75	1.00	0.75	0.50	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	34.52	8.44	7.07	1.90	0.21	0.11	0.42	0.42	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	35.67	6.32	5.48	1.12	0.42	0.70	0.56	0.14	0.00
glioblastoma cell line:T98G	10485-107A8	24.72	11.04	13.13	6.18	0.99	0.22	0.33	0.66	0.00
glioma cell line:GI-1	10413-106B8	23.14	7.03	14.06	1.17	1.17	0.00	0.29	0.59	0.00
globus pallidus - adult, donor10196	10175-103C4	24.05	10.93	14.58	1.46	2.19	1.46	1.46	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	21.48	9.52	8.30	5.13	3.17	2.93	1.95	0.49	0.00
globus pallidus, adult, donor10258	10367-105F7	9.58	10.95	10.95	0.00	2.74	1.37	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	15.45	10.13	7.46	3.73	0.00	1.60	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	78.31	22.02	19.58	0.00	2.45	4.89	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	10.93	10.93	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	15.68	0.00	10.45	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	9.60	4.80	5.44	1.60	0.32	0.00	0.32	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	10.10	16.99	5.51	5.05	2.30	0.46	0.00	1.38	0.00
hIPS +CCl2, biol_rep2	14384-156C1	12.80	11.43	10.52	5.94	2.29	0.00	0.46	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	9.02	12.88	12.88	4.51	0.64	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	11.50	18.68	20.12	1.44	0.00	0.00	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	11.66	12.35	6.86	2.74	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	12.14	5.52	7.72	3.31	1.10	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	13.79	18.39	8.91	0.86	0.29	0.86	0.57	0.57	0.00
heart - mitral valve, adult	10205-103F7	24.81	10.76	8.37	13.75	2.09	0.90	0.60	0.30	0.00
heart - pulmonic valve, adult	10206-103F8	25.10	14.64	10.46	13.86	0.00	0.78	1.83	0.52	0.00
heart - tricuspid valve, adult	10207-103F9	20.82	5.00	7.49	0.00	0.83	1.67	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	29.79	13.06	8.77	6.94	3.06	0.20	0.20	0.61	0.00
heart, adult, diseased, donor1	10051-101G6	28.53	8.52	6.81	14.05	0.85	0.00	0.85	1.70	0.00
heart, adult, pool1	10016-101C7	19.32	7.13	8.51	3.91	0.92	0.23	0.23	0.46	0.00
heart, fetal, pool1	10046-101G1	47.44	36.25	14.79	52.16	1.75	0.82	0.62	0.82	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	12.96	2.16	1.85	0.93	0.31	0.31	0.62	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	17.84	19.03	8.32	7.14	0.00	1.19	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	26.96	15.58	11.71	6.41	2.21	0.55	0.22	0.77	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	28.28	21.48	11.29	5.70	1.94	0.36	0.24	0.85	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	26.48	17.79	12.33	10.00	2.73	0.40	0.00	0.91	0.00
hepatoma cell line:Li-7	10484-107A7	12.12	3.23	3.67	1.56	0.67	0.00	0.00	0.00	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	31.26	27.54	7.44	4.62	1.01	1.31	0.50	0.20	0.00
hippocampus - adult, donor10196	10169-103B7	18.93	8.52	12.30	3.79	0.00	1.89	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	23.27	11.02	11.43	4.49	1.02	1.22	1.22	0.61	0.00
hippocampus, adult, donor10258	10374-105G5	12.95	11.95	10.95	4.48	0.00	4.48	0.50	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	18.68	8.81	8.11	3.52	0.35	2.11	1.76	0.00	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	21.97	17.70	12.82	21.97	1.22	1.22	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	17.48	11.00	9.03	7.07	1.18	0.00	0.20	0.59	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	14.47	13.46	7.11	9.14	0.25	0.25	0.51	0.76	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	10.71	11.28	14.66	18.04	1.13	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	8.78	9.55	14.46	14.72	0.26	0.26	0.00	1.55	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	7.97	13.29	11.01	13.29	0.38	0.38	0.38	1.14	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	14.31	21.31	11.97	17.52	0.88	0.58	0.00	2.04	5.26
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	12.06	25.42	4.95	17.23	0.86	0.43	0.22	1.29	3.23
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	21.27	21.69	7.92	16.68	0.83	0.42	0.00	0.83	5.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	23.44	27.47	12.31	15.87	2.13	1.89	0.47	0.71	4.26
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	20.73	22.34	7.07	10.45	0.80	0.16	0.16	1.77	4.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	33.67	27.61	11.45	10.10	1.35	0.67	0.67	0.00	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	17.84	12.99	8.29	10.02	0.78	0.00	0.47	0.78	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	16.21	9.83	6.88	15.72	0.49	0.00	0.49	2.46	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	10.47	20.95	14.84	20.07	0.00	0.00	0.87	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	8.02	15.65	18.33	16.23	0.76	0.38	0.00	0.76	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	8.72	10.47	13.08	13.95	1.74	0.87	0.44	0.44	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	10.00	17.49	15.99	22.49	0.50	0.50	0.00	1.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	5.46	25.24	7.35	10.17	0.57	0.38	0.19	0.75	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	6.82	25.46	12.28	12.28	0.91	0.91	0.45	0.91	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	5.01	24.43	7.20	10.34	1.57	0.63	0.00	1.25	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	16.66	18.62	7.19	17.47	0.33	0.49	0.33	0.65	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	10.16	24.10	5.52	16.84	0.58	1.45	0.29	0.58	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	10.76	18.23	5.98	17.04	0.90	0.30	0.60	0.00	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	17.18	13.30	10.35	9.24	0.74	0.92	0.55	1.11	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	11.98	13.41	6.56	7.99	0.29	1.43	1.14	0.29	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	17.15	17.97	8.17	18.78	2.45	0.41	0.82	2.04	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	9.15	13.03	18.31	17.60	1.06	1.06	0.70	1.06	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	11.40	11.72	13.62	9.82	1.58	0.63	0.63	0.95	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	12.10	13.32	14.83	9.99	0.61	0.00	0.00	0.91	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	8.27	17.58	5.17	17.58	0.52	0.00	2.07	0.00	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	9.30	25.90	6.64	13.95	0.66	0.00	0.00	0.00	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	8.21	19.24	7.44	14.88	0.77	0.26	0.51	1.03	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	13.80	16.11	8.44	11.76	1.53	0.77	0.00	1.28	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	16.66	28.77	9.09	7.57	0.00	0.76	0.76	3.03	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	18.48	15.12	6.05	10.75	0.34	0.34	1.01	1.34	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	13.28	10.63	7.25	8.94	1.69	0.72	0.24	0.97	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	18.27	15.15	8.91	17.38	0.89	0.45	0.00	0.89	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	18.54	15.61	13.66	14.15	2.44	0.00	2.93	0.49	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	9.47	12.53	18.64	12.84	1.53	0.31	0.00	1.53	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	13.01	71.57	55.31	172.42	0.00	0.00	0.00	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	7.61	14.23	14.56	18.20	0.66	0.33	0.00	0.66	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	12.59	24.08	6.57	17.51	0.00	0.00	0.00	0.55	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	12.67	25.69	9.05	17.01	0.72	0.72	0.36	0.36	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	7.12	22.42	8.54	16.37	1.42	1.07	0.71	1.07	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	8.35	20.29	13.13	9.55	0.00	0.00	0.00	1.19	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	18.82	31.15	13.00	27.63	1.08	0.41	0.27	0.54	3.79
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	14.55	18.59	8.62	11.31	0.27	0.27	0.00	0.81	1.89
immature langerhans cells, donor1	11904-125F5	23.25	31.72	1.21	0.48	0.00	0.48	1.21	0.00	0.00
immature langerhans cells, donor2	11905-125F6	31.69	16.63	0.79	0.79	0.79	1.58	3.96	0.79	0.00
insula, adult, pool1	10039-101F3	29.90	24.51	13.72	8.61	0.85	3.69	1.99	0.95	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	22.44	5.53	4.23	1.95	2.28	0.98	1.30	0.33	0.00
kidney, adult, pool1	10017-101C8	23.13	11.92	9.71	13.42	0.40	0.30	0.30	0.70	0.10
kidney, fetal, pool1	10045-101F9	34.94	21.29	17.19	26.38	1.49	0.99	1.49	0.50	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	54.54	17.33	23.15	1.85	2.98	1.56	0.14	0.43	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	10.78	4.98	3.32	0.14	0.28	0.00	0.28	0.28	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	14.86	2.57	8.44	7.52	0.73	0.00	0.18	0.18	0.00
left atrium, adult, donor1	10079-102A7	21.79	9.26	5.99	6.54	0.54	0.00	0.54	0.54	0.00
left ventricle, adult, donor1	10078-102A6	17.70	8.60	4.05	1.01	1.52	0.00	0.00	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	13.41	7.93	8.21	3.01	1.37	0.27	0.27	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	7.90	3.23	2.16	1.44	0.36	0.72	0.00	0.72	0.00
leiomyoma cell line:15242A	10570-108B3	3.26	3.80	2.17	0.00	0.00	0.00	0.54	0.54	0.00
leiomyoma cell line:15425	10571-108B4	11.17	3.89	5.10	0.49	0.24	0.24	0.00	1.21	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	6.35	6.35	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	11.50	2.09	12.55	1.05	0.00	0.00	1.05	2.09	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	28.92	24.32	5.08	1.06	1.30	2.13	1.42	0.71	0.00
liposarcoma cell line:KMLS-1	10782-110G8	8.59	6.87	4.84	0.31	0.00	0.31	0.62	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	21.20	8.53	5.24	0.00	0.61	0.12	0.37	0.12	0.00
liver, adult, pool1	10018-101C9	23.34	8.43	6.16	2.27	1.30	0.00	0.00	0.16	0.00
liver, fetal, pool1	10086-102B5	17.87	5.64	3.76	2.82	0.00	0.00	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	12.54	7.73	7.73	2.77	1.17	1.60	0.44	0.15	0.00
locus coeruleus, adult, donor10252	10165-103B3	17.35	6.27	7.94	4.98	1.66	1.48	1.48	0.55	0.18
locus coeruleus, adult, donor10258	10375-105G6	10.16	8.18	6.21	1.69	0.85	0.85	0.56	0.56	0.00
locus coeruleus, newborn, donor10223	10362-105F2	17.67	13.88	12.62	7.57	1.26	0.42	0.00	0.84	0.00
lung adenocarcinoma cell line:A549	10499-107C4	15.92	8.17	5.12	0.14	0.83	0.00	0.00	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	24.82	4.14	17.24	2.07	1.38	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	25.84	10.28	4.61	0.92	1.98	0.00	0.13	0.26	0.00
lung, adult, pool1	10019-101D1	17.72	16.18	7.68	1.06	0.71	0.59	0.71	0.00	0.00
lung, fetal, donor1	10068-101I5	42.24	36.82	17.12	6.85	0.57	3.42	0.57	0.57	0.00
lung, right lower lobe, adult, donor1	10075-102A3	25.20	16.95	7.79	2.75	0.00	0.46	1.83	0.92	0.00
lymph node, adult, donor1	10077-102A5	26.03	12.78	4.26	1.42	0.95	0.47	0.47	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	33.10	19.73	5.04	0.00	2.19	0.88	0.44	0.88	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	29.13	21.13	11.17	8.90	1.96	1.81	0.60	0.45	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	29.73	16.99	9.34	19.54	0.85	2.55	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	15.98	11.10	5.77	1.78	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	16.39	5.81	8.51	0.42	0.21	0.62	0.00	0.00	0.00
mature adipocyte, donor3	12233-129G1	16.59	6.64	5.69	1.66	0.24	0.24	0.24	0.24	0.00
mature adipocyte, donor4	12234-129G2	17.11	11.58	5.79	2.11	0.79	0.00	0.00	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	80.53	22.16	20.25	0.00	3.10	0.48	0.95	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	14.66	3.38	13.54	10.15	0.00	1.13	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	25.01	12.51	10.85	6.99	0.92	1.29	1.47	0.37	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	15.25	14.30	12.71	6.67	0.32	1.27	0.64	0.64	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	16.63	26.87	8.96	20.47	0.43	3.84	1.28	1.28	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	18.90	17.38	12.99	6.92	0.51	2.87	1.18	1.35	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	25.25	11.04	9.34	9.97	1.06	2.55	2.55	0.21	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	9.63	11.56	17.34	0.00	0.00	1.93	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	100.48	0.00	43.06	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	21.54	17.23	8.26	5.38	0.36	1.44	1.79	0.00	0.36
medulla oblongata - adult, donor10196	10174-103C3	6.49	6.49	6.49	5.84	0.65	0.00	0.65	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	22.76	9.44	10.06	7.89	0.93	1.24	0.46	0.62	0.00
medulla oblongata, adult, pool1	10038-101F2	20.49	14.12	10.53	6.12	1.14	1.63	0.57	0.41	0.00
medulla oblongata, newborn, donor10223	10361-105F1	20.48	9.03	10.07	4.51	0.35	0.35	1.39	0.69	0.00
medulloblastoma cell line:D283 Med	10838-111E1	28.78	16.61	23.25	9.52	3.32	0.66	0.22	0.44	0.00
medulloblastoma cell line:ONS-76	10759-110E3	21.03	6.85	6.11	1.96	0.49	0.61	0.24	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	22.42	17.82	5.46	5.89	1.29	0.43	0.43	0.43	0.00
melanoma cell line:G-361	10465-106H6	13.84	6.79	5.70	0.27	0.27	0.27	0.81	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	9.95	2.17	3.62	0.36	0.18	0.00	0.00	0.36	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	54.63	21.15	20.27	7.93	1.76	0.00	0.00	4.41	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	70.25	39.14	28.51	13.74	8.30	0.78	0.26	1.04	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	9.82	11.51	5.22	0.46	0.31	0.31	0.00	0.46	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	7.82	4.73	2.54	1.09	0.36	0.00	0.18	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	7.04	4.14	3.73	0.41	0.41	0.41	0.41	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	7.59	4.50	3.23	0.14	0.56	0.00	0.00	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	6.74	5.20	4.24	1.35	0.39	0.00	0.00	0.19	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	16.66	2.78	10.41	0.00	1.39	0.00	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	6.18	2.57	5.49	0.51	0.69	0.00	0.00	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	5.52	3.68	4.49	0.35	0.12	0.35	0.12	0.23	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	8.75	7.69	5.31	0.53	0.40	0.13	0.13	0.53	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	6.48	4.46	4.73	0.41	0.41	0.00	0.14	0.27	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	7.11	3.27	5.41	0.85	0.71	0.14	0.00	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	10.21	2.63	7.25	0.33	0.33	0.00	0.00	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	7.47	5.26	3.18	0.97	0.28	0.42	0.00	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	10.82	4.54	5.59	0.00	1.05	1.05	0.70	1.40	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	5.51	2.65	3.88	0.82	0.20	0.41	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	5.03	1.08	5.03	1.08	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	6.52	2.38	2.07	0.21	0.31	0.10	0.00	0.10	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	7.30	1.82	3.42	0.00	0.23	0.00	0.00	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	9.65	6.71	10.07	0.42	0.42	0.42	0.00	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	7.32	5.38	3.74	0.75	0.30	0.00	0.30	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	8.49	2.63	4.64	1.23	0.61	0.26	0.00	0.18	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	6.26	4.05	5.89	1.47	0.00	0.00	0.37	0.74	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	10.30	1.14	5.44	0.86	0.29	0.29	0.00	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	12.63	8.00	8.84	1.26	0.00	0.00	0.42	0.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	7.31	7.76	5.48	1.37	0.46	0.00	0.00	0.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	12.02	8.95	4.09	0.77	0.00	0.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	11.52	5.50	3.93	0.26	0.52	0.00	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	12.02	7.09	3.70	0.62	0.31	0.31	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	13.42	7.53	3.77	0.71	0.00	0.24	0.00	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	15.57	6.09	4.40	0.68	0.34	0.34	0.34	0.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	9.82	7.86	5.50	0.39	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	12.05	10.19	3.71	0.46	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	14.13	11.83	5.48	0.00	0.29	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	13.61	7.59	5.35	0.22	0.00	0.22	0.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	15.62	5.29	5.29	0.24	0.72	0.00	0.48	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	12.47	9.53	0.73	1.47	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	10.74	7.72	5.03	0.67	0.00	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	11.46	6.55	5.73	0.41	0.82	0.41	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	10.31	6.44	3.01	1.72	0.00	0.00	0.00	0.86	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	19.14	5.47	0.00	0.00	0.00	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	11.69	8.44	4.55	0.32	0.65	0.00	0.00	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	5.82	8.73	1.45	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	17.06	10.13	3.20	0.00	0.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	12.27	4.09	4.09	0.00	0.82	0.82	1.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	12.44	8.16	3.89	0.39	0.39	0.39	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	4.20	2.10	2.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	8.94	11.92	2.98	0.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	4.77	4.77	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	10.08	8.30	6.52	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	18.28	7.31	8.53	1.22	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	9.50	10.77	4.43	0.00	0.00	0.63	0.00	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	6.21	7.24	1.38	0.69	0.34	0.00	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	6.45	0.00	2.15	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	6.89	6.89	3.44	0.00	0.00	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	10.19	6.93	3.26	0.81	0.00	0.00	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.15	9.53	0.79	0.00	0.79	0.00	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	5.90	4.72	2.95	0.00	0.59	0.00	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	7.48	4.36	1.56	0.62	0.00	0.62	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	6.68	5.35	1.34	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	5.91	4.73	3.55	2.37	0.00	0.00	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	7.70	0.00	2.57	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	9.64	6.20	5.51	3.44	0.69	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	14.35	7.92	7.92	4.95	1.98	0.00	0.00	1.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	14.58	3.36	8.97	0.00	1.12	0.00	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	15.90	5.09	6.36	3.18	1.27	0.00	0.00	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	20.96	5.64	9.67	4.84	0.40	0.00	0.00	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	26.17	4.36	8.72	2.18	2.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	16.47	5.07	5.07	2.53	0.00	0.00	0.00	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	13.35	5.46	11.53	4.25	0.00	0.00	0.00	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	4.52	4.52	4.52	4.52	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	14.00	4.12	5.77	4.12	1.65	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	10.72	5.16	6.55	2.18	0.20	0.00	0.00	0.20	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	7.46	9.09	4.22	3.89	0.32	0.00	0.65	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	6.11	0.00	4.07	4.07	0.00	0.00	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	11.61	3.87	4.64	0.00	0.77	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	19.84	3.54	5.91	1.42	1.42	0.00	0.00	0.47	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	19.23	4.40	6.02	6.02	0.46	0.00	0.23	0.00	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	12.82	4.27	4.27	0.00	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	9.35	8.22	5.86	4.32	0.51	0.21	0.10	0.10	0.00
mesothelioma cell line:Mero-25	10850-111F4	8.85	4.31	9.53	1.13	0.91	0.23	0.00	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	22.98	4.89	11.00	2.69	0.73	0.00	0.24	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	19.49	7.97	7.53	4.87	1.33	0.22	0.00	0.66	0.00
mesothelioma cell line:Mero-82	10853-111F7	22.34	10.78	9.20	4.99	0.79	0.79	0.00	0.26	0.00
mesothelioma cell line:Mero-83	10854-111F8	10.72	5.11	9.02	5.96	1.02	0.34	0.00	0.17	0.00
mesothelioma cell line:Mero-84	10855-111F9	7.58	3.79	5.31	1.77	0.25	0.00	0.25	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	14.29	6.83	5.80	6.83	0.21	0.21	0.41	0.21	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	17.39	6.46	8.45	2.15	0.99	0.50	0.50	0.00	0.00
mesothelioma cell line:NCI-H226	10846-111E9	13.57	7.60	7.24	5.25	0.36	0.90	0.18	0.72	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	23.40	8.37	7.17	5.30	0.17	0.17	0.17	0.34	0.00
mesothelioma cell line:NCI-H28	10845-111E8	21.38	9.67	12.98	11.96	0.76	0.51	0.76	0.25	0.00
mesothelioma cell line:No36	10857-111G2	12.40	1.30	14.35	4.24	1.30	0.33	0.00	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	19.51	2.44	7.04	0.27	0.27	0.27	0.81	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	14.78	23.80	7.48	1.92	0.00	0.38	0.38	0.38	0.00
migratory langerhans cells, donor2	11902-125F3	15.63	20.27	5.50	0.85	0.12	0.85	0.12	0.12	0.00
migratory langerhans cells, donor3	11903-125F4	20.82	26.20	5.20	1.26	0.36	1.44	0.18	0.36	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	18.61	4.57	8.16	1.96	0.33	0.00	0.33	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	15.47	12.93	0.85	1.06	0.21	0.21	0.00	0.42	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	28.33	5.76	3.69	0.23	0.92	0.00	0.46	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	15.79	20.17	3.04	0.76	0.38	1.71	1.52	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	45.64	28.46	2.77	0.00	0.92	0.55	0.55	0.37	0.00
myeloma cell line:PCM6	10474-106I6	33.01	12.26	3.16	0.59	0.20	0.20	0.00	0.40	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	17.76	10.15	1.01	0.51	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	18.44	13.93	7.26	0.39	1.77	0.78	0.39	0.59	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	10.25	3.45	8.36	0.33	1.34	0.11	0.11	0.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	9.34	1.54	6.91	0.37	0.96	0.07	0.00	0.15	0.00
nasal epithelial cells, donor2	12227-129F4	7.73	6.62	3.31	7.18	0.55	0.00	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	19.10	11.27	9.20	5.75	0.92	0.69	0.69	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	13.66	6.55	12.72	2.99	0.94	0.75	0.19	0.19	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	66.01	28.68	14.76	10.54	4.01	1.05	0.42	2.53	0.00
neuroblastoma cell line:NH-12	10555-107I6	15.84	25.72	6.71	3.17	0.75	0.56	0.19	0.56	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	56.22	44.36	8.54	4.51	1.19	1.19	0.95	2.14	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	27.87	20.11	8.71	4.91	2.69	0.32	0.32	0.48	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	27.77	19.32	8.05	6.04	1.81	0.81	0.40	0.81	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	39.42	18.44	3.81	1.27	0.64	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	11.18	2.93	2.93	0.80	0.00	0.27	0.53	0.00	0.00
neutrophil PMN, donor1	12133-128D9	59.50	14.87	44.62	0.00	0.00	14.87	14.87	14.87	0.00
neutrophil PMN, donor2	12137-128E4	26.56	53.12	0.00	0.00	0.00	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	37.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	42.28	19.11	9.13	26.89	0.68	0.51	0.34	0.68	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	18.41	6.40	5.60	8.81	0.80	0.80	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	11.22	5.77	5.45	0.96	0.96	0.00	0.00	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	15.50	5.52	4.73	1.05	0.26	0.00	1.05	0.26	0.26
nucleus accumbens, adult, pool1	10037-101F1	21.93	21.84	11.44	9.66	0.84	2.81	1.12	0.19	0.00
occipital cortex - adult, donor10196	10172-103C1	16.48	18.54	10.30	22.66	4.12	0.00	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	25.76	12.34	10.73	12.34	1.07	1.88	1.61	1.07	0.00
occipital cortex, newborn, donor10223	10355-105E4	29.12	27.66	10.55	8.37	0.36	2.91	2.91	0.73	0.00
occipital lobe, adult, donor1	10076-102A4	15.48	23.88	11.02	2.62	0.26	1.31	1.05	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	44.20	31.32	6.87	8.58	2.57	1.29	1.72	0.86	0.00
occipital pole, adult, pool1	10036-101E9	27.04	27.44	16.40	8.12	1.18	2.76	0.71	0.55	0.08
olfactory region, adult	10195-103E6	18.53	13.76	11.27	6.11	0.76	1.72	1.15	0.76	0.00
optic nerve, donor1	10277-104E7	4.00	14.01	20.01	6.00	0.00	4.00	8.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	20.39	7.52	7.63	7.06	1.59	0.46	0.11	0.23	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	8.11	5.36	6.87	3.71	0.69	0.14	0.00	0.14	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	18.96	10.33	5.08	5.76	0.34	0.85	0.34	0.51	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	22.99	8.89	8.66	1.04	1.16	1.04	0.12	1.16	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	9.41	5.29	5.59	0.29	1.18	0.00	0.29	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	41.11	14.02	6.54	0.00	1.87	2.80	1.87	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	12.51	6.79	10.18	0.00	0.64	0.21	0.21	0.21	0.00
ovary, adult, pool1	10020-101D2	26.64	14.41	9.26	2.01	1.31	0.17	0.17	0.35	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	7.88	4.58	4.40	0.00	0.55	0.18	0.18	0.00	0.00
pancreas, adult, donor1	10049-101G4	27.28	23.52	9.41	0.94	1.88	0.00	0.00	2.82	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	34.38	13.98	9.22	4.75	1.12	0.56	0.00	0.56	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	18.74	3.07	6.47	0.68	1.02	0.17	0.00	0.68	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	11.92	3.48	2.48	0.50	0.17	0.33	0.00	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	20.96	22.06	12.45	8.79	1.28	1.83	1.37	0.37	0.18
parietal cortex, adult, donor10258	10373-105G4	8.81	13.21	13.95	12.48	0.73	2.20	0.00	0.73	0.73
parietal lobe - adult, donor10196	10171-103B9	17.87	13.17	11.29	4.70	0.00	1.88	1.88	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	19.38	14.54	13.68	13.40	1.14	2.00	0.86	0.29	0.00
parietal lobe, adult, pool1	10034-101E7	26.00	21.59	11.63	9.08	0.53	2.38	1.06	0.26	0.00
parietal lobe, fetal, donor1	10072-101I9	43.64	30.06	5.82	15.52	2.91	1.94	0.00	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	19.81	19.81	14.58	4.86	0.37	1.87	1.50	1.12	0.37
parotid gland, adult	10199-103F1	36.38	11.72	8.02	6.17	1.23	1.23	0.00	1.23	0.00
penis, adult	10200-103F2	25.24	14.50	9.67	8.59	0.00	0.00	1.07	1.61	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	46.67	20.27	8.92	1.12	2.23	0.19	0.19	0.56	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	20.25	4.95	5.97	4.52	0.58	0.29	0.00	0.29	0.00
pineal gland - adult, donor10196	10179-103C8	10.97	6.45	11.61	15.48	1.94	0.00	0.65	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	20.73	12.44	14.81	24.87	0.59	2.96	1.78	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	21.95	10.66	8.78	10.66	0.00	1.88	1.25	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	15.18	5.06	11.13	10.12	1.01	0.00	2.02	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	30.23	15.11	21.89	10.42	4.69	2.61	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	19.58	11.07	16.17	3.40	1.70	0.00	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	43.22	18.81	9.25	1.94	0.97	0.22	0.22	0.54	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	25.03	16.29	8.48	7.42	0.79	0.13	0.26	0.79	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	17.12	5.45	4.82	0.16	0.78	0.31	0.00	0.31	0.00
pons, adult, pool1	10033-101E6	13.60	12.65	12.05	5.16	1.38	1.64	1.03	0.34	0.00
postcentral gyrus, adult, pool1	10032-101E5	28.68	23.36	11.51	8.54	1.13	2.70	1.22	0.00	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	37.65	23.01	6.27	0.00	0.00	4.18	4.18	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	16.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	0.00	0.00	0.00	0.00	0.00	11.74	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	17.19	6.41	4.66	3.20	0.87	0.29	0.15	0.15	0.00
prostate cancer cell line:PC-3	10439-106E7	36.12	8.71	10.89	2.00	1.82	0.36	0.00	0.36	0.00
prostate, adult, pool1	10022-101D4	22.76	12.33	14.33	4.53	1.00	0.82	0.36	0.45	0.00
putamen, adult, donor10196	10176-103C5	19.12	12.75	8.97	6.14	0.24	0.94	0.94	1.42	0.00
putamen, adult, donor10252	10152-102I8	31.37	9.80	13.73	3.92	1.96	3.92	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	8.74	13.11	13.11	1.09	0.00	0.00	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	14.01	11.36	11.36	4.35	0.24	1.93	1.45	0.24	0.00
putamen, newborn, donor10223	10365-105F5	23.99	16.49	7.50	12.74	0.75	0.75	0.75	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	34.33	20.07	4.36	2.04	1.75	0.29	0.87	0.29	0.00
rectum, fetal, donor1	10067-101I4	29.21	25.04	16.69	6.95	2.78	4.17	4.17	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	18.02	10.18	9.54	5.51	0.42	0.21	0.85	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	5.80	0.41	7.46	1.66	0.00	0.00	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	31.71	19.98	16.50	16.90	1.19	1.59	1.69	0.80	0.00
retinoblastoma cell line:Y79	10475-106I7	23.38	16.63	20.00	7.27	1.04	0.52	0.00	0.52	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	19.55	15.12	5.41	2.09	1.23	0.49	0.25	0.25	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	44.99	23.34	20.53	24.75	1.69	0.84	0.28	0.84	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	12.13	9.09	3.03	0.76	0.00	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	8.25	7.28	3.72	1.78	0.81	0.16	0.49	0.00	0.32
salivary acinar cells, donor2	11772-123I8	12.94	7.02	5.65	6.33	0.69	0.41	0.69	0.41	0.00
salivary acinar cells, donor3	11773-123I9	13.24	5.96	5.30	7.28	0.00	0.00	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	34.89	21.16	9.72	22.88	0.57	2.29	0.57	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	14.84	8.26	8.35	0.93	0.34	0.25	0.17	0.08	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	13.28	7.05	6.70	0.94	0.94	0.00	0.24	0.12	0.00
seminal vesicle, adult	10201-103F3	22.75	10.05	11.64	6.88	0.53	1.06	3.17	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	21.62	8.02	15.79	4.37	2.43	0.73	1.46	0.49	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	7.55	5.03	3.77	0.25	0.50	0.00	0.00	0.50	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	11.04	4.01	4.01	1.00	1.00	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	11.69	8.73	8.06	7.79	0.67	0.54	0.13	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	37.25	24.65	6.85	1.55	1.77	0.77	0.33	0.44	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	17.16	10.84	4.90	1.81	0.52	0.26	0.26	0.39	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	24.12	12.06	13.48	12.06	0.71	1.42	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	26.15	21.35	16.43	2.64	2.28	0.12	0.00	0.48	0.00
skeletal muscle, fetal, donor1	10066-101I3	25.13	16.08	6.03	3.02	5.03	1.01	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	27.14	13.57	6.79	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	23.99	16.41	7.57	5.05	0.00	1.89	0.00	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	162.76	76.04	69.04	12.34	11.67	3.34	3.34	2.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	26.79	14.18	9.46	1.89	3.47	1.58	1.26	1.26	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	44.14	15.42	22.94	0.58	2.89	0.77	0.77	0.58	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	28.52	13.19	11.54	9.56	1.15	0.49	0.82	0.33	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	15.92	6.92	25.09	2.09	1.45	0.32	0.32	0.97	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	91.31	69.52	11.55	6.76	2.18	2.62	0.65	2.83	0.00
small intestine, adult, pool1	10024-101D6	30.58	18.04	10.39	6.69	0.84	0.72	0.72	0.72	0.00
small intestine, fetal, donor1	10064-101I1	25.80	16.22	7.86	4.91	0.49	0.98	0.74	0.74	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	11.80	11.28	11.28	1.03	2.05	0.51	1.03	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	16.80	11.89	8.53	5.43	2.07	0.78	0.52	1.29	0.00
somatostatinoma cell line:QGP-1	10781-110G7	28.41	16.35	5.36	1.61	1.07	0.80	0.54	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	13.99	9.64	8.03	3.44	1.15	1.15	0.92	0.00	0.23
spinal cord, adult, donor10252	10159-103A6	16.17	11.43	9.46	4.34	1.18	1.58	0.39	0.79	0.00
spinal cord, adult, donor10258	10369-105F9	7.61	8.99	10.38	2.08	0.69	2.08	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	23.17	18.30	10.37	10.37	0.61	1.83	0.00	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	20.66	17.45	11.48	4.59	0.00	0.92	0.46	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	12.70	4.33	4.18	0.30	0.75	0.00	0.15	0.15	0.00
spleen, adult, pool1	10025-101D7	28.97	17.51	10.24	2.53	0.77	1.10	1.54	0.44	0.00
spleen, fetal, pool1	10044-101F8	36.07	28.21	13.03	5.40	1.59	1.83	2.22	0.95	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	23.50	15.73	8.18	7.56	0.52	0.52	0.52	0.41	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	18.61	6.08	2.47	4.18	0.57	0.19	0.00	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	44.38	27.26	12.23	12.58	2.45	2.10	1.05	2.10	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	18.76	8.21	7.82	5.86	1.17	0.39	0.39	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	17.78	10.36	11.82	3.60	1.35	0.56	0.56	0.11	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	12.71	8.05	5.93	1.69	0.00	0.00	0.42	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	29.61	3.38	6.35	0.85	0.42	0.42	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	38.45	16.02	2.14	5.34	1.07	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	34.18	10.82	11.39	11.39	1.71	0.00	1.14	1.14	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	15.99	9.55	9.55	3.53	0.62	2.91	1.25	0.21	0.00
substantia nigra, adult, donor10258	10371-105G2	6.21	6.72	16.55	4.14	0.00	0.52	0.52	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	17.66	9.89	7.07	3.53	0.00	2.83	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	31.41	15.59	9.63	12.84	1.15	0.46	0.92	0.46	0.00
temporal lobe, adult, pool1	10031-101E4	26.96	23.40	13.05	6.44	0.68	3.65	1.36	0.76	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	44.87	27.07	7.12	12.82	2.85	0.00	0.00	1.42	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	42.64	33.40	7.91	6.59	2.20	1.32	0.00	0.44	0.00
tenocyte, donor1	11763-123H8	15.36	7.68	4.89	1.75	0.35	0.35	0.00	0.70	0.00
tenocyte, donor2	11765-123I1	16.79	6.49	3.82	0.38	0.76	0.38	0.00	0.76	0.00
tenocyte, donor3	11768-123I4	14.46	6.30	7.78	0.37	0.00	0.37	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	41.30	17.17	16.32	18.36	3.57	1.02	0.34	0.34	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	7.71	8.32	6.63	1.85	0.92	0.77	0.15	0.31	0.00
teratocarcinoma cell line:PA-1	10807-111A6	14.10	17.67	6.35	4.03	2.63	0.46	0.31	0.15	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	32.50	16.63	15.74	8.25	3.68	0.63	0.63	0.63	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	51.43	36.68	33.66	5.29	4.16	0.76	0.38	0.76	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	22.58	23.23	18.65	12.54	5.13	0.76	0.44	0.76	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	42.34	22.15	15.31	7.82	2.61	0.33	0.65	1.95	0.00
testis, adult, pool1	10026-101D8	26.31	32.10	11.70	2.58	0.54	0.32	0.75	0.75	0.00
testis, adult, pool2	10096-102C6	42.85	53.23	18.04	4.06	2.26	2.26	2.26	1.80	0.00
thalamus - adult, donor10196	10168-103B6	11.04	4.42	20.98	4.42	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	19.38	11.88	10.31	5.47	1.25	2.34	0.94	0.47	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	7.70	15.40	26.17	3.08	0.00	1.54	0.00	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	9.88	4.94	6.75	2.64	0.49	0.66	0.82	0.00	0.00
thalamus, newborn, donor10223	10366-105F6	9.21	5.18	5.75	6.33	0.00	0.58	0.58	0.00	0.00
throat, adult	10209-103G2	28.21	14.48	7.49	5.99	0.50	0.50	1.00	0.50	0.00
throat, fetal, donor1	10061-101H7	34.43	17.98	10.06	13.71	1.52	0.30	1.52	0.30	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	37.76	35.57	8.94	8.35	0.20	1.39	0.79	0.40	0.00
thymus, adult, pool1	10027-101D9	34.70	29.03	18.19	6.96	1.19	0.80	0.89	0.50	0.00
thymus, fetal, pool1	10043-101F7	37.51	30.24	16.11	21.82	1.87	1.56	1.87	0.31	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	16.09	4.25	9.17	0.80	0.53	0.80	0.00	0.27	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	21.23	5.45	10.34	1.12	1.54	1.12	0.28	0.56	0.00
thyroid, adult, pool1	10028-101E1	28.65	14.09	12.13	15.86	0.93	0.37	0.28	0.56	0.00
thyroid, fetal, donor1	10060-101H6	35.59	13.18	9.76	8.17	0.53	2.64	2.90	0.26	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	12.32	9.24	0.00	6.16	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	33.49	20.00	6.98	5.81	0.00	0.00	0.70	0.47	0.23
tongue, fetal, donor1	10059-101H5	25.22	16.16	6.31	3.55	2.36	0.00	1.18	0.79	0.39
tonsil, adult, pool1	10047-101G2	43.98	24.14	14.12	8.72	1.80	1.30	1.00	0.70	0.00
trachea, adult, pool1	10029-101E2	19.71	10.72	8.18	3.27	0.41	0.41	0.33	0.57	0.00
trachea, fetal, donor1	10058-101H4	22.70	15.77	8.08	3.85	0.77	1.15	1.15	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	15.59	5.67	4.61	0.00	0.00	0.00	0.00	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	19.05	15.10	8.92	7.60	0.41	0.81	0.51	0.10	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	45.75	11.91	13.16	1.72	1.57	0.63	0.31	0.16	0.00
tridermal teratoma cell line:HGRT	10694-109G1	17.12	15.22	3.81	1.90	0.00	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	14.98	4.66	3.30	1.69	0.51	0.08	0.17	0.00	0.00
umbilical cord, fetal, donor1	10057-101H3	25.04	8.35	4.17	4.17	0.00	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	29.52	25.59	16.21	5.80	1.19	2.22	2.05	0.17	0.00
uterus, fetal, donor1	10055-101H1	35.83	18.43	9.73	2.56	1.54	1.54	1.02	0.00	0.00
vagina, adult	10204-103F6	15.51	10.34	7.75	1.29	1.94	0.00	0.00	0.65	0.00
vein, adult	10191-103E2	27.62	17.10	11.18	3.95	0.44	1.10	0.88	0.22	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	19.76	12.82	6.14	4.54	0.53	0.00	0.53	0.80	0.00